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Abstract 
The hydrolysis of biomass yields a sugar mixture consisting mainly of glucose, arabinose and 
xylose. Effective metabolism of all sugars in biomass by a microorganism is regarded as 
essential for commercial biofuel production. However, two of the major challenges that we are 
currently faced with are the transport of sugars into the microorganism and the co-utilization of 
these sugars once they are in the cell.  
In order to engineer simultaneous multiple sugar utilization in Escherichia coli, a better 
understanding of the pentose sugar pathways is required. In this work, we have investigated the 
transport of sugars and the regulation of the sugar metabolic pathways within E. coli to engineer 
a strain most efficient in producing biofuels. While extensive research has been carried out to 
examine the transport mechanisms of sugars into the cell, this research shows that in addition 
to transporters that pump sugars into the cell, a number of proteins that pump sugars out of the 
cell are also expressed by E. coli. Using genetic approaches, we have demonstrated that by 
either deleting or overexpressing these efflux transporters we can respectively increase or 
decrease the uptake of pentose sugars, namely arabinose and xylose, which are abundantly 
present in the hemicellulose of biomass.  
In addition to examining transport mechanisms, this work has also focused on studying and 
controlling the metabolism of the pentose sugars. By using a novel targeted approach, we can 
utilize constitutive promoters and chromosomal integration to control the expression of certain 
metabolic genes, while relieving repression effects. This enables us to regulate the metabolism 
of pentose sugars such as xylose that are utilized by the cell less efficiently and allows for 
simultaneous metabolism of sugars, hence leading to a more efficient biofuel production 
process. 
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CHAPTER 1: Introduction and motivation 
 
1.1 Motivation 
Economic and geopolitical factors such as high oil prices, environmental concerns, and supply 
instability have increased the need to develop renewable, cleaner energy sources. Biofuels are 
an attractive sustainable transportation fuel because they can be produced from renewable 
sources and can be readily incorporated into the current transportation infrastructure. Many also 
have the advantages of low toxicity, higher vapor pressure and a net reduction in the levels of 
atmospheric carbon dioxide [1]. A goal set forth in “The United States Bioenergy Vision and 
Sustainable Feedstock Supply” by the Biomass R&D Technical Advisory Committee is that, by 
year 2030, 30% of current U.S. petroleum-based fuels will be replaced by biofuels [2]. However, 
there are several factors limiting large scale, efficient processes for biofuels production. Among 
the many challenges, there exists the need for optimizing cellular systems of microbial hosts. In 
particular, three of the key issues that we are concerned with are (1) the inability for 
microorganisms to efficiently and simultaneously ferment all sugars found in biomass 
feedstocks, (2) tolerate stresses caused by alcohol accumulation and the presence of inhibitors, 
and (3) process hardiness. The work presented here primarily aims to tackle the issue of 
inefficient co-utilization of sugars in biomass by microbes; a solution to this challenge will 
present a large stride towards a large-scale economical biofuel generation.  
1.2 Overview of the production of biofuels 
The production of biofuels mainly consists of the following steps: pretreatment and hydrolysis of 
the biomass, fermentation of the sugars from the biomass by microbes, and finally distillation 
and other separation processes to retrieve the end products. Improvement and optimization at 
each step of the process is required to make the overall large-scale production of biofuels more 
efficient and economical. 
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The types of biofuels from microbes include bioethanol, biodiesel, biobutanol and 
methane/biogas. Biodiesel and bioethanol are the only fuels presently being produced on a 
large industrial scale, and bioethanol fermentation is by far the largest scale microbial process 
[3]. Biobutanol is another promising fuel that is being developed. While ethanol has the 
advantages of having a higher octane rating and lower toxicity, and requires lower energy for 
production (due to its lower boiling point), butanol has the benefits of a higher energy content, 
lower corrosivity, and lower hygroscopicity [4]. However, it is also important to note that 
biobutanol is produced at a much lower titer, and is not immediately compatible with the current 
fuel production infrastructure. Aside from butanol, other higher alcohols, alkanes, and various 
types of oils are possible biochemically derived biofuels (Figure 1.1). It is not clear yet which 
one(s) will be the ideal biofuel, and the answer to this question would depend on additional 
factors, such as the type of biomass available, particular climatic conditions, composition of 
engine emissions, and combustion performance. Therefore, even though it may be beneficial to 
develop a better biofuel alternative to ethanol as a long-term solution, short-term goals that aim 
to optimize bioethanol production are also desirable. The work described here is in the context 
of ethanol production, but much of the research analysis and results can be extended towards 
producing other biofuels of interest in the future. 
Biomass represents the most abundant renewable carbon source available for the production of 
bioenergy. The US has the potential to produce nearly 1.3 billion dry tons of biomass annually 
corresponding to a displacement of as much as one-third of current transportation fuel demands 
[5]. To produce biofuels, biomass is first pretreated to solubilize lignin and to break open 
crystalline cellulose. Effective pretreatments must improve enzymatic hydrolysis, minimize 
carbohydrate losses, and prevent formation of by-products that might inhibit subsequent 
hydrolysis and fermentation steps. Different types of pretreatments include physical, chemical, 
and biological processes. The pretreatment step is then followed by a hydrolysis step in which 
3 
 
enzymes break open polymer chains and convert cellulose and hemicellulose into fermentable 
sugars such as glucose and xylose. The product of these two steps is then ready for 
fermentation by microorganisms that metabolize sugars into biofuels. The process is 
summarized in Figure 1.2.  
At present, the commercial production of biofuels in the U.S. is largely based on the use of 
starch in grains such as maize. This is a mature commercial technology with well understood 
economics and the U.S. is now the world’s largest producer of starch based ethanol as a 10% 
additive to gasoline (known as E-10). However, this is not a viable long-term option as 
increasing demand for corn based ethanol would negatively impact the food and feed industries 
and result in higher corn prices. In addition, the requirements for arable land would be 
significant and impractical. Under current conditions, corn based ethanol can only displace a 
small proportion of gasoline (~10%). It is therefore necessary to pursue other long term ethanol 
feedstocks to replace corn.  
During the fermentation process, two microorganisms commonly used to produce ethanol are 
Saccharomyces cervisiae (yeast) and Zymomonas mobilis [6, 7, 8]. Both yeast and Z. mobilis 
produce ethanol and carbon dioxide as principal fermentation products. Yeast is predominantly 
used in the industry to covert starch to ethanol because of its genetic tractability and widespread 
industrial use [9]. However, it does not produce comparable ethanol yields to Z. mobilis [7, 10]. 
Z. mobilis is an obligately ethanologenic bacterium and hence is an appealing candidate for 
ethanol production. The challenge, however, is that both microorganisms are unable to utilize 
multiple sugars. While they readily consume hexoses such as glucose, they cannot natively 
metabolize pentose sugars such as arabinose and xylose. Therefore, heterologous 
complementation or significant genetic modification is required.  
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The current energy productivity (ratio of the energy obtained from ethanol to energy expended 
in its production) is 1.3-1.6, which is not optimal [11]. Additionally, the current choice of 
feedstock and overall ethanol production process is not a long-term solution to the growing 
energy demands. Research in the various fields related to the biofuel production process is 
essential so that we can overcome the limitations and challenges of the current situation. 
1.3 Lignocellulosic biomass 
An ideal biomass resource should be high yielding, have low production costs, be readily 
available, and have consistent desirable chemical concentrations. The feasibility of an energy 
crop depends largely on its production costs, cost of converting the biomass to usable energy, 
and cost of competing fuels. Lignocellulosic materials (e.g. wood, grass, forestry waste, 
agricultural residues, and municipal solid wastes) are most advantageous because they are 
non-food feedstocks, abundant, and cheap, which make them an attractive substrate for biofuel 
production. Lignocellulose is a three-dimensional polymeric composite formed by plants as 
structural material. It is composed of three main fractions: cellulose (~45% of dry weight), 
hemicellulose (~30% of dry weight), and lignin (~25% of dry weight). Table 1.1 shows the 
specific composition of potential lignocellulosic biomass resources [5]. Lignin, polyphenolic in 
structure, is the largest non-carbohydrate fraction of lignocellulose and therefore cannot be 
utilized in the fermentation process. Cellulose is a high molecular weight linear polymer of β-1,4-
linked D-glucose units and often appears as a highly crystalline material. The basic repeating 
unit is the dissacharide cellobiose. The secondary and tertiary conformation of cellulose, as well 
as its close association with lignin, hemicellulose, starch, protein and mineral elements, makes 
cellulose a hydrolysis-resistant molecule. Cellulose can be hydrolyzed chemically by diluted or 
concentrated acid, or enzymatically (typically by cellulases). By cellulose saccharification, 
glucose can be obtained and then fermented to produce biofuels.  Hemicelluloses are branched 
polysaccharides consisting of a mixture of hexoses (D-galactose, L-galactose, D-mannose, L-
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rhamnose, L-fucose), pentoses (D-xylose, L-arabinose), and uronic acids (D-glucuronic acid). 
Hemicellulose is more easily hydrolyzed than cellulose, and the exact composition of 
hemicellulose depends on the source of the raw material, but it is most abundant in xylan 
(xylose polymer) [12]. Complete hydrolysis of xylan involves three main enzymes: endo-β-1-4-
xylanase which primarily targets the internal β-1-4 bonds between xylose units, exoxylanase 
that releases xylobiose units, and β-xylosidase that releases xylose from xylobiose and short 
chain xylooligosachharides [13]. 
A potential lignocellulosic feedstock is switchgrass. Switchgrass shows promise due to its high 
productivity, suitability for marginal land quality, low water and nutritional requirements, 
environmental benefits, and flexibility for multipurpose uses. According to Morrow et al. [14], a 
mature bioenergy crop production, in which conversion of both pentoses and hexoses is 
assumed, would yield 330-380 L of ethanol per Mg of dry switchgrass. The theoretical ethanol 
production potential from highly adapted switchgrass varieties is between 5000 and 6000 L/ha. 
In comparison, the theoretical ethanol yield from corn starch is only about 4000 L/ha [5]. 
1.4 Sugar utilization by microbes 
The ideal microorganism for biofuel production should possess high substrate utilization and 
processing capacities, fast and deregulated pathways for sugar transport, good tolerance to 
inhibitors and product, and high metabolic fluxes and should produce a single fermentation 
product [15]. 
This project is mainly concerned with efficient substrate utilization. As mentioned before, the 
hydrolysis of hemicellulose yields a sugar mixture consisting mainly of glucose, arabinose and 
xylose. Effective metabolism of all sugars in biomass is regarded as essential for commercial 
ethanol production. A significant amount of research has been devoted to using metabolic 
engineering to construct bacterial and yeast strains which feature traits most efficient in ethanol 
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production using hemicellulose sugars. Three main emerging microbial platforms are: 
Saccharomyces cerevisiae, Zynomonas mobilis and Escherichia coli. Z. mobilis and yeast 
ferments hexose sugars such as glucose, but cannot natively metabolize the pentose sugars: 
xylose and arabinose. Unlike yeast or Z. mobilis, E. coli can natively metabolize all three sugars 
[16-18]. Metabolic engineering has enabled the addition of pathways for pentose sugar 
utilization in several of these microorganisms. Examples include: S. cerevisiae, Zymobacter 
palmae [19], Z. mobilis, and the recently engineered derivative of Pseudomonas putida S12 
containing E. coli genes for xylose metabolism [20]. Furthermore, a great deal of work is 
focused on the isolation and characterization of Pichia stipitis, Clostridium thermocellum and 
Clostridium phytofermentans [21-23].  
In the case of yeast, strains capable of xylose and arabinose catabolism have been engineered 
[24-27], but continued optimization of these strains is required. Two types of pentose pathways 
have been constructed: the oxidoreductase pathway and the isomerase pathway. Both xylose 
and arabinose can be metabolized through each of these pathways, although arabinose 
assimilation involves additional steps in both cases [28]. All four possible pathway variants have 
been previously constructed [28-31], and all feed into native yeast metabolism via D-xylulose or 
D-xylulose-5-phosphate. Once converted to xylulose-5-phosphate, these sugars are further 
metabolized through the native pentose phosphate pathway. Ethanol titers of 36 g/L from 
switchgrass have been achieved [32]. Even though arabinose and xylose can be catabolized by 
these engineered yeast strains, reported growth rates remain suboptimal for economical 
production of biofuels [15]. 
Z. mobilis can natively consume only hexose sugars such as glucose, fructose, and sucrose. 
However, metabolic engineering has enabled this organism to consume pentose sugars as well. 
Studies on recombinant strains created at NREL (The National Renewable Energy 
Laboratories) have involved the construction of integrant xylose-utilizing strains and additionally 
7 
 
an integrant xylose/arabinose-utilizing strain designated AX101. These strains are able to utilize 
pentose sugars efficiently and produce high yields of ethanol [33]. Z. mobilis has several 
advantages over yeast. Considerable faster rates of sugar uptake and ethanol production, better 
ethanol tolerance, simpler growth conditions, and higher reported productivities (120-200 g/L hr 
in continuous processes with cell recycle compared to only 30-40 g/L hr for yeast), make this 
organism a promising microbe for biofuel production. Another big advantage of this organism is 
that it is not susceptible to catabolite repression effects like in the case of E. coli. Therefore, 
once pentose sugar utilization is optimized in this organism, challenges related to repression by 
glucose do not need to be overcome. Engineered Z. mobilis strains are reported to produce 
ethanol at concentrations above 60 g/L within 48 hours (in a 65 g/L glucose and 65 g/L xylose 
mixture) [33]. Some concerns, however, are that Z. mobilis may be less robust than yeast and 
more susceptible to contamination in large-scale processes. Also, there is a lack of experience 
with large-scale Z. mobilis fermentation in the ethanol industry, which makes the switch from 
yeast to Z. mobilis challenging.  
Several studies have explored the issue of using mixed cultures (mixture of several isolated or 
engineered strains) for more efficient ethanol conversion [34-35]. These studies have shown 
that mixed cultures can result in 2-12% higher ethanol yields than that of a single 
microorganism. For example, recent studies have shown that a mixed culture of substrate-
selective engineered E. coli strains (one glucose-deficient and one xylose-deficient) consumed 
the sugars in 15% less time than the individual strains when allowed to ferment in a mixture of 
glucose and xylose. Despite these positive findings, fermentations with a single organism 
continue to be researched. The difficulties associated with the stability of mixed cultures and the 
ease of bioprocessing of a single host system are the key reasons why there is continuing 
interest in finding a single organism solution to the biofuel problem. 
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While it is possible to engineer microorganisms like Saccharomyces cerevisiae and Z. mobilis 
so that they are able to ferment pentose sugars by introducing genes from other organisms 
containing the requisite pathways, similar sugar utilization efficiencies to that in E. coli have not 
yet been achieved. Other advantages to using E. coli are that much is known about the sugar 
metabolism pathway and transport in this organism, and the bacterium has a robust genetic 
system. Unfortunately, sugar co-utilization in E. coli is hindered by a number of factors, including 
catabolite repression, sugar transport limitations and intracellular sugar concentration [36-38]. 
The bacterium will always consume just one sugar while repressing the metabolism of all others 
[39-41]. In particular, E. coli will first consume glucose, then arabinose, and then finally xylose. 
To overcome this characteristic, several genetic changes have been made and more efficient 
strains of E.coli have been engineered. An important improvement to wild-type E. coli has been 
to introduce the genes pdc (pyruvate decarboxylase) and adhB (alcohol dehydrogenase II) from 
Z. mobilis to maximize ethanol production during mixed acid fermentation. Additionally, Yomano 
et al. showed that the deletion of methylglyoxal synthase gene increased sugar co-matabolism 
in ethanol producing E. coli [42]. However, a lag in xylose metabolism was observed and they 
found that injection of small amounts of air was required to relieve this lag. Strains constructed 
by Trinh et al. also achieved high ethanol yields and their minimal cell approach and elementary 
mode (EM) analysis eliminated the effects of catabolite repression in glucose-xylose sugar 
mixtures [43]. The reported ethanol yield for their strain, TCS083/pL0I297, is 0.49 ± 0.01 (g 
ethanol/g sugar). This is very close to the theoretical yield of 0.51g/g and higher than previously 
reported ethanol yields for engineered E. coli (K011 and FBR5/pL0I297) [44-45]. However, the 
specific growth rate on glucose was reduced in this minimal strain. When grown at a high 
specific growth rate, pronounced catabolite repression was observed and preferential glucose 
consumption comparable to that of the wild-type strain was seen under aerobic conditions. 
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Clearly, there is room for further studies and different approaches. E. coli serves as a model 
organism to test various approaches because of its native ability to degrade a mixture of sugars 
and because it can be easily engineered according to rational strain design with well-
established molecular techniques. The final goal is to be able to genetically engineer E. coli to 
efficiently and robustly utilize multiple sugars to maximize substrate utilization and optimize 
ethanol production during fermentation. 
1.5 Sugar metabolic pathway in E.coli and catabolite repression 
The E. coli metabolic pathway of the three sugars: glucose, arabinose and xylose, is illustrated 
in Figure 1.3. During the uptake of glucose, one unit of ATP is used to convert the glucose to D-
glucose-6-phosphate. The transport of glucose into the cell occurs through the 
phosphotransferase system (PTS). D-glucose-6-phosphate is then converted to fructose-6-
phosphate and finally to pyruvate through the glycolysis pathway. ATP is consumed during 
glycolysis, but four units are also produced; this results in a positive net energy change of two 
molecules of ATP [46]. In the case of the pentose sugars, arabinose and xylose are both 
converted to D-xylulose-5-phosphate before they enter the pentose phosphate pathway and are 
converted to fructose-6-phosphate. From this point in the pathway, they go through glycolysis to 
produce pyruvate. Finally, under anaerobic conditions, the pyruvate is converted to mixed acid 
fermentation products such as lactate, acetate, and most importantly, biofuels like ethanol. 
The regulatory system that prioritizes the sequential metabolism of sugars in E. coli is carbon 
catabolite repression, which involves cyclic AMP, cyclic AMP-binding protein (CRP), enzymes of 
the phophotransferase system, and other components [38]. Through this system, glucose 
effectively blocks the expression of sugar specific transporters and essential enzymes required 
for the metabolism of alternative sugars. 
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The transport of glucose into the cell occurs through the PTS using the glucose-specific PTS 
permease. The phosphoenolpyruvate-dependent glucose PTS is responsible for the transport 
and the phosphorylation of the sugar in a two-step reaction: (1) the phosphoenolpyruvate (PEP), 
catalyzed by the enzyme EI, uses the protein HPr as an intermediate phosphoryl donor; (2) HPr 
then donates the phosphoryl group to a histidine residue in the EII domains of various substrate 
specific transporters, and from there to the carbohydrate during its uptake through the 
membrane domain as shown in Figure 1.4 [38].  
Regulation of carbon catabolite repression in E. coli is brought about the modulation of the 
phosphorylation state of EIIAGlc (the EIIA domain of the glucose transporter). EIIAGlc is 
preferentially dephosphorylated when the cells are growing rapidly in the presence of easily 
metabolizable sugars, such as glucose. Regulation by phosphorylated EIIAGlc occurs by 
activation of the membrane bound enzyme adenylate cyclase, which is capable of synthesizing 
cyclic AMP (cAMP). Once cAMP has been produced, it binds its receptor protein CRP, and the 
cAMP-CRP complex is then able to activate the promoters of several catabolic genes and 
operons. In summary, when glucose is present, the PTS system tightly limits the cAMP-CRP 
complex formation and hence hinders the metabolic pathways of other sugars (e.g. pentose 
sugars), and prevents their co-utilization in the cell. 
1.6 Pentose sugars 
The two pentose sugars abundantly present in hemicellulose of biomass are arabinose and 
xylose. Figure 1.3 illustrates the metabolic pathways of these sugars in E. coli before they enter 
the pentose phosphate pathway, and highlights the metabolic genes and transporters for each 
sugar.  
The genes responsible for arabinose uptake into the cell are araE and araFGH [47-49]. Both 
transporters are induced by arabinose. AraE is a low-affinity transporter, which means that it is 
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responsible for transporting arabinose when the sugar concentration is high outside the cell. It 
uses proton motive force as its energy source. On the other hand, AraFGH is a high affinity 
transporter, responsible for transport when the sugar concentration is low outside the cell [50]. 
The araF gene encodes the arabinose-binding protein (ABP), the araG gene encodes a 
probable ATPase subunit, and the araH gene encodes an integral membrane subunit [51]. It 
forms an ATP binding cassette, using energy from ATP as its energy source. A schematic of 
these transporters is shown in Figure 1.4. The enzymes required for the metabolism of 
arabinose are coded by the araBAD operon. These encode for L-arabinose isomerase (araA), 
L-ribulokinase (araB), and L-ribulose-5-phosphate-4-epimerase (araD). The synthesis of these 
proteins is controlled by the cAMP binding protein (i.e. the catabolite gene activator protein, 
CRP) and both positively and negatively controlled by the product of the araC gene. The 
regulatory region for the araC gene is adjacent to the regulatory region for the araBAD operon 
and their respective promoters are transcribed in opposite directions. The araC protein has 
three regulatory functions: 1) positive control of araBAD, 2) negative control of araBAD, and 3) 
negative control of araC [52]. In the presence of arabinose, AraC positively activates the 
transcription of the araBAD operon and the araE and araF genes. Both the araBAD operon and 
the araC gene are positively regulated via the binding of the cAMP-CRP complex to a single 
site. Therefore positive regulation of the araBAD operon requires the presence of both 
arabinose and CRP. In the absence of arabinose AraC acts as an inhibitor and represses the 
transcription of the metabolic genes araA, araB and araD, hence inhibiting the metabolism of 
arabinose.  
Analogous to the arabinose transporters are the xylose transporters, xylE (low affinity 
transporter) and xylFGH (high affinity transporter) [53-54]. xylF encodes for the periplasmic 
xylose-binding protein, xylG encodes for ATPase, and xylH encodes for permease. The operon 
responsible for xylose metabolism is xylAB. The xylA gene encodes for D-xylose isomerase, 
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and the xylB gene encodes for xylulokinase. The regulator that positively controls the 
transcription of this operon is xylR. [55]. XylR, along with CRP, binds cooperatively to activate 
transcription of operons involved in transport and catabolism of D-xylose. Gene induction occurs 
when the physiological inducer, D-xylose, binds to XylR and when cellular cyclic AMP levels are 
high. It has also been found that arabinose represses the xyl operons and previous work has 
shown that AraC is responsible for the repression caused by arabinose on the expression of the 
xylose metabolic genes [56]. 
The effects of catabolite repression and the role that they play in sugar utilization have been 
extensively studied. However, the mechanisms for the regulation of the sugar hierarchy are not 
fully understood and optimal ways to bypass this hierarchy have not yet been achieved. Three 
hierarchical systems need to be overcome in E. coli to achieve maximum and simultaneous 
utilization of all the sugars present in biomass: the glucose-arabinose hierarchy, glucose-xylose, 
hierarchy, and the arabinose-xylose hierarchy. In this work we aimed to increase pentose sugar 
metabolism in two ways: 1) hypothesize that sugar transport and intracellular sugar 
concentration are key limiting factors in efficient sugar utilization and study ways in which we 
can reduce these limitations, and 2) analyze and understand sugar hierarchy and devise 
techniques to overcome it. The first part of this thesis primarily focuses on transport of the 
pentose sugars and aims to understand the role that efflux transporters play on pentose sugar 
metabolism. The second part of this thesis focuses on the hierarchy that exists between glucose 
and xylose and describes the work done to engineer a strain capable of co-utilizing these two 
sugars simultaneously.  
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1.7 Figures and tables 
Table 1.1. Detailed compositional analysis of potential lignocellulosic biomass [5].  
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Figure 1.1. Schematic representation of engineered metabolic pathways to produce candidate 
biofuels.  
 
Figure 1.2. Overview of the production of biofuels.  
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Figure 1.3. Sugar metabolic pathway in E. coli.  
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Figure 1.4. The phosphoenolpyruvate-carbohydrate phosphotransferase system (PTS). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5. Schematic of arabinose transporters. 
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CHAPTER 2: Identification and analysis of the putative pentose sugar 
efflux transporters in Escherichia coli 
 
2.1 Introduction and background 
One of the factors mentioned in our hypothesis that limits metabolism of the pentose sugars in 
E. coli is transport. The metabolic genes of pentose sugars such as arabinose and xylose are 
controlled by genes that are induced by high sugar concentrations. Hence, the transport 
mechanism of the pentose sugars through the cell and the factors that contribute to the 
increased or decreased levels of intracellular sugar concentration needs to be understood in 
detail. This helps us gain knowledge of how sugar metabolism in the cell can be better 
regulated. 
Escherichia coli expresses proteins that not only transport sugars into cells but also a number 
that transport them out of the cell. In contrast to the influx transporters described in the previous 
chapter, which are responsible for sugar uptake, there is also another class of transporters that 
has been identified, which is responsible for sugar efflux. The canonical example is the SET 
family of transporters: SetA, SetB, and SetC [57-58].  Efflux transporters are membrane 
transporter proteins that pump substances out of the cell. There is a vast family of efflux 
transporters, mainly classified based on the energy source required. These include: ATP-
binding cassette superfamily (ABC), small multidrug resistance family (SMR), resistance-
nodulation-cell division superfamily (RND), multidrug and toxic compound extrusion family 
(MATE), and major facilitator superfamily (MFS) [59]. Of interest is the MFS class of efflux 
transporters. These transporters use a proton symporter as an energy source to pump the 
substance of interest out of the cell. In E. coli, 64 such genes can be identified on the basis of 
sequence similarity, and the exact number could be somewhat higher [60]. 
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Efflux transporters have been extensively studied in the literature in the context of multi-drug 
resistance (MDR). These transporters are responsible for pumping out substances that are 
harmful to the cell. In E. coli, efflux systems like AcrAB and EmrAB pump out toxins such as 
tetracycline and chloramphenicol out of the cell. These transporters are essential for drug 
resistance in bacteria, and hence a lot of research has been dedicated to studying them [61-68]. 
However, there is almost no literature that studies them in the context of sugar efflux. Little is 
known about sugar efflux transporters or necessarily why E. coli has them. One possible 
mechanism is to relieve sugar-phosphate stress. In particular, Sun and Vanderpool 
demonstrated that SetA participates in the glucose-phosphate stress response [69]. However, 
they found that SetA does not efflux alpha-methylglucoside, the nonmetabolizable sugar analog 
used to elicit the response. Another proposal is that they function as safety valves, preventing 
excess sugar from accumulating within the cell. However, this hypothesis has not yet been 
tested. 
The only genes that have been characterized in the context of sugar efflux are ydeA, setA, setB, 
setC. Bost et al. [70] and Carolé S et al. [71] characterized ydeA as an arabinose efflux 
transporter in E. coli. Experiments suggest that when ydeA is overexpressed, intracellular sugar 
accumulation of arabinose is lowered. In addition, inactivation of ydeA decreases the efflux of 
arabinose which is indicated by higher intracellular arabinose concentration, thereby affecting 
the expression of AraC-regulated genes [72]. Both of these results help identify ydeA as a 
successful sugar efflux transporter. The sugar efflux transporter (SET) genes: setA, setB and 
setC are characterized by Jia Yeu Liu, Paul F. Miller et al [58]. setA and setB were found to be 
responsible for glucose and lactose efflux. In addition, they have broad specificity for various 
glucosides or galactosides. setC was not an efflux transporter of glucose or lactose, but no 
further experiments were carried out to determine the substrates of setC.  
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In this work, we investigated L-arabinose and D-xylose efflux in E. coli. Sequence analysis 
identified 31 candidate sugar efflux transporters in E. coli based on homology to known sugar 
efflux transporters (Table 2.1). This list was prepared by identifying all the genes that belonged 
to the same COG (Clusters of Orthologous Groups of proteins) as ydeA. The COG’s are 
identified by NCBI by comparing sequences encoded in complete genomes, representing major 
phylogenetic lineages. Each COG consists of individual proteins or groups of paralogs from at 
least 3 lineages and thus corresponds to an ancient conserved domain. All the genes in E .coli 
within COG2814, the cluster that included ydeA and the SET genes, were tested. Using genetic 
approaches, we tested whether these candidate efflux transporters target arabinose and xylose. 
We were able to identify multiple putative arabinose efflux transporters but interestingly none for 
xylose. 
2.2 Materials and methods 
Media and growth conditions. Luria-Bertani liquid and solid medium (10 g/L tryptone, 5 g/L 
yeast extract, 10 g/L NaCl) was used for routine bacterial culture and genetic manipulation. All 
experiments were performed in tryptone broth (10g/L tryptone, 5g/L NaCl) at 37°C. Antibiotics 
were used at the following concentrations: ampicillin at 100 µg/mL, chloramphenicol at 20 
µg/mL, and kanamycin at 40 µg/mL. Inducer isopropyl-β-D-galactopyranoside (IPTG) was used 
at a concentration of 2 mM unless otherwise specified. All experiments involving the growth of 
cells carrying the helper plasmid pKD46 were performed at 30 oC. Loss of pKD46 was achieved 
by growth at 42 oC under nonselective conditions on LB agar. The removal of the antibiotic 
cassette from the FLP recombinant target (FRT)-chloramphenicol/kanamycin-FRT insert was 
obtained by the transformation of the helper plasmid pCP20 into the respective strain and 
selection on ampicillin at 30 oC. Loss of pCP20 was obtained by growth at 42 oC under 
nonselective conditions on LB agar. Primers were purchased from IDT, Inc. Enzymes were 
purchased from New England Biolabs and Fermentas. 
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Strain and Plasmid Construction. Bacterial strains and plasmids used in this study are 
described in Tables 2.2 and 2.3 respectively. All strains are isogenic derivatives of Escherichia 
coli K-12 strain MG1655. All cloning steps were performed in E. coli strain DH5α (phi-80d 
lacΔm15 enda1 recA1 hsdR17 supE44 thh-1 gyrA96 relAΔlacU169). Targeted gene deletions 
and subsequent marker removal were made using the λRed recombinase method of Datsenko 
and Wanner [73]. The generalized transducing phage P1vir was used in all genetic crosses 
according to standard methods [74-75]. 
The plasmids pKD3 and pKD4 were used as templates to generate scarred FRT mutants as 
previously described. The primers used to create the deletions of each efflux transporter gene 
are displayed in Table 2.4. Mutations were checked by PCR using primers that bound outside 
the deleted region. These check primers are shown in Table 2.5 and were used in combination 
with test primers c1 (TTATACGCAAGGCGACAAGG) and c2 (GATCTTCCGTCACAGGTAGG) 
for cat, and k1 (CAGTCATAGCCGAATAGCCT), k2 (CGGTGCCCTGAATGAACTGC), for kan. 
Prior to the removal of the antibiotic resistance marker, the constructs resulting from this 
procedure were moved into a clean wild-type background by P1vir transduction. 
The plasmid pPROBE venus was constructed by digesting the plasmid pQE80L-venus by EcoRI 
and NheI and cloning the fragment into pPROBE-gfp[tagless] digested by EcoRI and NheI. This 
replaced the gfp[tagless] by the fast-folding yfp variant Venus in pPROBE [75]. Venus 
transcriptional fusions were made by amplifying the promoter of interest and then cloning these 
PCR fragments into the multiple cloning site of pPROBE venus. The araBAD promoter (region 
67884-68377) was amplified using primers TD088f (sequence: 5’- GGA AAG GTA CCC ATT 
CCC AGC GGT CG) and TD088r (sequence: 5’- GAC TAG AAT TCG CCA AAA TCG AGG 
CC). The xylA promoter (region 3726575-3727102) was amplified using primers TD065f 
(sequence: 5’- GGA AAG GTA CCT CGA TCT TTT TGC CA) and TD065r (5’- GAC TAG AAT 
TCG CGA TCG AGC TGG TC). The promoters of the potential efflux genes of interest were 
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cloned using the primers listed in Table 2.6 and the region amplified is noted. The PCR 
fragments were then digested with KpnI and EcoRI (sequences underlined) and cloned into the 
multiple cloning site of the pPROBE venus vector. The resulting transcriptional fusions were 
transformed into MG1655 wild-type E. coli strains and the mutated strains containing the 
deletions of interest. The primers used to check the mutations for all the pPROBE venus 
transcriptional fusions are KK010f (sequence: 5’- TAA ACT GCC AGG AAT TGG GG) and 
SS123r (sequence: 5’- GGG TCT AGA TTA TTT GTA TAG TTC ATC CAT GCC). 
Plasmids overexpressing the genes of interest were constructed by cloning the respective gene 
into the multiple cloning site of pTrc99A under the control of a strong IPTG inducible promoter, 
Ptrc [76]. The primers used to clone the specific genes are shown in Table 2.7, with the enzyme 
restriction sites underlined. The check primers used are KK027f (sequence: 5’- GAC AGC TTA 
TCA TCG ACT GC) and KK027r (sequence: 5’- CTG GCA GTT CCC TAC TCT CG). 
Fluorescence assays. End-point measurements of the fluorescent reporter system were made 
using a Tecan Safire 2 microplate reader. 3 mL cultures were grown overnight in tryptone media 
at 37°C and then subcultured 1:30 after which 0.45mL was transferred to a single well of a 
polypropylene, 2.2 ml, deep, square, 96-well microtiter plate (VWR; 82006-448). Cultures were 
then grown at 37°C while shaking at 600 rpm on a microplate shaker (VWR). After an optical 
density of 0.05 was reached, the cells were induced with varying concentrations of the sugar of 
interest (either arabinose or xylose). Extracellular sugar concentrations ranged from 1 mM to 10 
mM. In addition, strains containing the expression plasmids for the genes of interest were also 
induced with IPTG. Final volumes in each well were adjusted to 0.5 mL for all cultures. When 
the cells reached an OD of 0.4-0.5, 100 µL of the culture was transferred from the deep-well 
plates to black, clear-bottomed Costar 96-well microtiter plates, and the fluorescence 
(excitation/emission λ, 515/530 nm, bandwidth 5nm, gain 92, and OD at 600nm (OD600) were 
measured. Fluorescence measurements are reported as the relative fluorescence normalized to 
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the optical density of the sample to correct for differences in cell density. All experiments were 
conducted in triplicates and average values with one standard deviation error bars are reported. 
2.3 Results 
Effect of deleting candidate sugar efflux transporters on arabinose metabolism. We 
identified 31 candidate sugar efflux transporters in E. coli based on homology to the known 
sugar efflux transporters: ydeA, setA, and setB. These homologs included a number of 
multidrug efflux transporters, both known and putative, along with five transporters involved in 
the uptake of various metabolites (shiA, kgtP, galP, nanT, and proP).  
If any of these genes encodes an efflux transporter of arabinose, then deleting the gene should 
increase the intracellular sugar concentration of arabinose. As an indirect measure of 
intracellular arabinose concentrations, we employed transcriptional fusions of araBAD promoter 
to Venus, a fast-folding variant of the yellow fluorescent protein [77]. The average activity of the 
araBAD promoter as determined using fluorescence is proportional to extracellular arabinose 
concentrations and presumably relative intracellular arabinose concentrations as well based on 
the known mechanism for regulation [78]. To test the effect of deleting these genes, we grew 
the cells in tryptone broth at varying concentrations of arabinose and then harvested the cells at 
late-exponential phase to determine relative araBAD promoter activities. The resulting data 
were fit to a Michaelis-Menten dose-response curve with the governing parameters, Vmax and 
Km, reported (Table 2.8).  
Deletion of the following eight genes was found to increase intracellular arabinose 
concentrations as compared to the wild-type control: setC, cmr, ynfM, mdtD, yfcJ, yhhS, emrD 
and ydhC. Deleting the other genes had no effect, with the dose-response curves 
indistinguishable from the wild-type control. A representative dose-response curve for the Δcmr 
mutant is shown in Figure 2.1. These results suggest that these eight genes encode arabinose 
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efflux transporters. Among them, only SetC has previously been implicated in sugar efflux 
based on its homology to SetA and SetB, two transporters known to efflux lactose [58]. Cmr, 
also known as MdfA, and EmrD are known multidrug efflux transporters. Over-expression of 
Cmr has also been shown to limit the uptake of isopropyl-β-D-thiogalactopyranoside (IPTG), an 
effect attributed to efflux [79]. YnfM, MdtD, YfcJ, and YdhC are uncharacterized MFS 
transporters. YhhS is also an uncharacterized MFS transporter that has been implicated 
glyphosate resistance [80].  
Interestingly, we did not observe any effect with the ydeA deletion strain, though we did observe 
an effect when overexpressing it as discussed below. As previously mentioned, this gene is 
known to encode an arabinose efflux transporter and Carolé and coworkers have shown that 
disrupting the ydeA gene increases intracellular arabinose concentrations. The lack of 
agreement between their results and ours may be due to the fact that they employed a strain 
lacking the arabinose metabolic genes, which dramatically increases intracellular arabinose 
concentrations as shown below, whereas our strain background was wild-type MG1655. 
Effect of over-expressing candidate sugar efflux transporters on arabinose metabolism. 
We also over-expressed these candidate sugar efflux transporters. If these genes encode 
arabinose efflux transporters, then over-expressing them should reduce intracellular arabinose 
concentrations. To express these genes, they were cloned on high-copy plasmids under the 
control of the strong, IPTG-inducible trc promoter. Once again, transcriptional fusions to the 
araBAD promoter were employed as indirect measures of intracellular arabinose and the results 
were recorded in terms of governing parameters for a Michaelis-Menten dose-response curve 
(Table 2.8). 
Over-expression of six genes was found to reduce intracellular arabinose concentrations: setC, 
ydeA, mhpt, ybdA, ydeE, and kgtP. A representative dose-response curve for ybdA is given in 
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Figure 2.2. Among the five, only setC and ydeA have been implicated in sugar efflux as 
discussed above.  YbdA, also known as EntS, has been implicated in enterobacterin transport 
[26] and is also involved in the resistance to multiple chemical stresses [81]. YdeE is an 
uncharacterized MFS transporter involved in dipeptide transport and resistance [82]. KgtP, 
interestingly, is known to be α-ketoglutarate transporter [83].  
When comparing these results with our deletion results, only setC gave a consistent result 
where loss of the gene increases intracellular arabinose and overexpression decreases it. Over-
expression of yfcJ, yhhS, emrD, and ydhC had no effect on intracellular arabinose 
concentrations. Three genes that gave a deletion phenotype were toxic to the cell when over-
expressed: cmr, ynfM, and mdtD.  
Overall, 12 genes were toxic to E. coli when over-expressed. Of the 31 genes, the set of 
transporters that resulted in cell death when over expressed no matter what IPTG concentration 
was used included: ycaD, ynfM, mdtD, bcr, ygcS and yjhB. Interestingly, the set of strains 
overexpressing these genes caused growth defects irrespective of whether the substrate was 
arabinose or xylose. To test that there is no other factor in the strain itself that is causing cell 
death the experiments were repeated with no IPTG added. In accordance with intuitive results, 
the curves imitate the control curve and the optical density of the cells reaches normal levels 
(0.4-0.6). These results are shown in Figures 2.3 and 2.4. 
To limit toxicity, the over-expression experiments were performed at two concentrations of the 
IPTG inducer. Both setC and ydeE were toxic to cell when expressed using the higher IPTG 
concentration; only at the lower concentration did we observe an effect. Conversely, we only 
observed an effect with ydeA and kgtP when they were induced at higher IPTG concentration. 
Only ybdA and mhpT decrease intracellular arabinose concentrations at both induction levels. 
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Xylose is not a target for any of the candidate efflux transporters. The candidate efflux 
transporters were also tested to determine if they have an effect on xylose metabolism. This is 
important so that we can find out whether all pentose sugars are substrates for the efflux 
transporters, or if the efflux transporters are specific to arabinose only (and possibly other 
sugars not tested in this work), but not xylose. Also, if we can find a set of transporters that 
efflux both arabinose and xylose, it would significantly reduce the amount of genetic engineering 
required to reach our goal. A similar approach was employed as before except that we used 
transcriptional fusions of the xylA promoter to Venus. The xylA promoter is positively regulated 
by XylR in response to xylose [55] and can equivalently be used to determine relative 
intracellular xylose concentration. Otherwise, the experiments were performed in an identical 
manner to the arabinose experiments. Despite the similarities between xylose and arabinose, 
we did not observe any change in intracellular xylose concentrations as compared to the wild-
type control when any of candidate genes were deleted or overexpressed (Figures 2.5 and 2.6). 
Arabinose is a substrate for most efflux transporters. The arabinose metabolic 
intermediate, ribulose-5-phosphate, is toxic to E. coli [84]. This may provide one possible 
explanation as to why arabinose may be effluxed from cells. It also suggests that arabinose 
itself may not be the target for efflux but rather an intermediate of arabinose metabolism. To test 
this hypothesis, we blocked different steps in arabinose metabolism by deleting the cognate 
gene and then determined how the mutation would affect our results concerning arabinose 
efflux. If arabinose is not the target for these transporters and the downstream metabolite is 
instead, then we expect that blocking metabolism will reduce the effect of these transporters. 
We tested three mutants: ΔaraA, ΔaraB, and ΔaraBAD. We did not test a ΔaraD mutant as 
arabinose is toxic in this strain. All strains lacking in araC suffered growth degradation when 
arabinose was used as a substrate for the growth cultures. AraC positively regulates the 
transcription of the arabinose of the four operons in the arabinose regulon in the presence of 
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arabinose. Therefore, in the absence of araC, the metabolic genes are not transcribed and the 
cells are not able to consume the substrate arabinose and hence suffer growth defects. 
Blocking any step in arabinose metabolism significantly increased the concentration of 
intracellular arabinose relative to the wild-type control. This is expected, as arabinose is no 
longer being metabolized in any of these strains. However, we did not observe any further 
increase when setC, mhpT, cmr, ynfM, mdtD, yfcJ, yhhS, and emrD were deleted as well 
(Figure 2.7). While these results suggest that these transporters may target ribulose-5-
phosphate, a simpler explanation is that arabinose concentrations are already high in these 
cells and eliminating efflux does not further increase arabinose concentration. 
The effect of overexpressing of setC, ydeE, and ydeA was most pronounced in a ΔaraA mutant, 
indicating that the three target arabinose (Figure 3.8). The data for mhpT and ybdA was more 
equivocal though again it indicates both target arabinose. Interestingly, we only observed a 
reduction in relative arabinose concentrations only when kgtP was overexpressed in a ΔaraB 
mutant or the wild type. These results suggest that ribulose may be the target for KgtP.  
Many arabinose efflux transporters are TolC dependent. In general, many efflux 
transporters are TolC dependent. Martin and Rosner previously found that the mar/sox/rob 
regulon was activated in a tolC mutant [85]. They proposed that this activation may be due to 
the accumulation of intracellular metabolites due to the loss of efflux. Chubiz and Rao 
subsequently demonstrated that this activation could partially be attributed to the accumulation 
of benzoic acid intermediates in the chorismate superpathway [86]. Based on these results, we 
tested whether any of the identified arabinose efflux transporters were TolC dependent. 
In an otherwise wild-type background, deleting tolC was found to increase intracellular 
arabinose concentrations (Figure 2.9A). The magnitude of this increase was similar to that 
observed with the efflux transporter knockouts. When both sets of mutants were combined, we 
27 
 
observed that the intracellular arabinose concentrations went back to wild-type levels in all 
cases except with EmrD. These results do not provide any useful information about the link 
between the efflux transporters and TolC as deletion of both sets of genes indicated no 
intracellular change in arabinose concentration. 
We also tested the effect of overexpressing efflux transporters in a ΔtolC mutant (Figure 2.9B). 
When the efflux transporters were over-expressed in the ΔtolC mutant, arabinose 
concentrations were reduced in all cases except with KgtP and YbdA. These results suggest 
that these two transporters are linked to TolC. We also found that the effect of over-expressing 
SetC was somewhat reduced in a ΔtolC mutant. Interestingly, we did not observe any increase 
in arabinose concentrations when tolC was deleted. This effect is entirely due to pTrc99A (data 
not shown). This plasmid was present in both control strains used for results shown in Figure 
2.9B. Why the empty plasmid has an effect is not known.  
Expression of efflux transporters is induced by arabinose. The last question explored was 
whether arabinose induced the expression of these transporters. To answer this question, we 
fused the promoters for these transporters to Venus and then tested whether they were 
activated by arabinose. Of the thirteen transporters, we were able to construct functional 
promoter fusions to all but four. Our transcriptional fusions to the mhpT, yfcJ, and mdtD 
promoters were not functional despite repeated attempts. In addition, the fusions to the setC 
and ydhC promoters were very weak and not included in our results as a consequence. 
Of the eight remaining functional promoters, only the ydeA and yhhS promoters were activated 
at significant levels (Figure 2.10). The remaining six promoters were also activated by arabinose 
though the effect is less than two fold. How these promoters, in particular for the ydeA and yhhS 
genes, are being activated by arabinose is not known. Interesting, ydeA is strongly induced by 
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arabinose yet deleting this gene does not affect intracellular arabinose concentrations. Only 
when over-expressed do we observe an effect. 
2.4 Discussion 
We identified 31 candidate sugar efflux transporters in E. coli based on sequence homology to 
known sugar efflux transporters and then tested to see whether they target arabinose and 
xylose. The results of this study are summarized in Table 2.9. Thirteen putative arabinose efflux 
transporters were identified based on their ability to alter intracellular arabinose concentration. 
Interestingly, no xylose transporters were identified. Eight of the thirteen arabinose efflux 
transporters were found to increase intracellular arabinose concentrations when deleted and six 
were found to decrease concentrations when overexpressed. Only one transporter, SetC, was 
found to yield reciprocal results when deleted or overexpressed. Among the thirteen putative 
transporters, only YdeA has previously been shown to be a sugar efflux transporter. A sequence 
homology comparison of each of the identified efflux transporters to the ydeA gene was carried 
out using LALIGN (Table 2.10). A few of the transporters have local homology in multiple 
regions but interestingly most of the homology occurs in the region of ~750-900 base pairs into 
the ydeA gene. Two of the efflux transporters, ydhC and ydeE, did not show significant 
homology at a particular location, but some homology was still noted at the 750-900 base pairs 
region.  
We cannot definitely say whether these putative transporters in fact efflux arabinose as we did 
not directly measure arabinose transport. All that we can say with certainty is that these 13 
transporters inhibit the accumulation of arabinose with efflux being a likely but not the only 
possible mechanism. Alternate mechanisms include the inhibition of the arabinose uptake and 
the efflux of other compounds that affect arabinose metabolism or possibly stimulate other efflux 
transporters.  
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A number of the identified efflux transporters have previously been shown to transport other 
compounds both in and out of the cell. Cmr, for example, is known to efflux a number of 
chemically unrelated compounds [87], so it is not entirely implausible that it effluxes arabinose 
as well. This is consistent with multidrug efflux transporters in general, which are known to have 
broad substrate specificities. What is surprising is that transporters such as KgtP, a known α-
ketoglutarate transporter [83], also inhibit arabinose uptake and perhaps efflux it as well. Clearly 
further research is required to identify the exact mechanisms for how these transporters affect 
arabinose uptake and efflux. 
Why would E. coli want to efflux arabinose from the cell? One possibility is to limit the 
accumulation of toxic sugar phosphates, such as the arabinose metabolic intermediate L-
ribulose-5-phosphate, within the cell. If the flux of arabinose is greater than the pentose 
phosphate pathway can accommodate, then L-ribulose-5-phosphate may accumulate within the 
cell due to an effective roadblock within the pathway. Under such a scenario, arabinose efflux 
transporters would provide a relief valve for the cell. A second possibility is to limit the 
accumulation of methylglyoxal, another toxic compound to E. coli [88]. Methylglyoxal synthase is 
thought to provide a relief value in glycolysis, preventing the buildup of dihydroxyacetone 
phosphate when inorganic phosphate is limiting. If the flux of arabinose is too high, it may 
overwhelm the glycolytic branch of the pathway leading to a buildup of dihydroxyacetone 
phosphate. Consistent with this model, the addition of cAMP to cells grown on arabinose or 
xylose, which increases the uptake of these two sugars, produces excess methylglyoxal, 
arresting cell growth [89]. Interestingly, the effect is less severe with arabinose, consistent with 
our result showing a lack of xylose efflux transporters. In addition, the overexpression of 
methylglyoxal synthase is lethal to cells grown on arabinose and xylose but not on glucose. 
Unlike arabinose and xylose dissimilation, glycolysis is linked to glucose transport through the 
phosphenolpyruvate transferase system [90]. In the case of arabinose and xylose dissimilation, 
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transport and metabolism are uncoupled. Arabinose efflux may provide a relief value to 
accommodate this uncoupling. Why there are not similar relief values for xylose is not known. 
Other outstanding questions concern the regulation of these transporters. Arabinose was found 
to induce the expression of many efflux transporters, where the effects were most pronounced 
for the YdeA and YhhS transporters. We and others have previously speculated that the 
multidrug antibiotic resistance (MDR) mechanisms in bacteria evolved in part as a mechanism 
to prevent the buildup of toxic metabolites. In fact, we found that 2,3-dihydroxybenzoate, an 
intermediate in enterobactin biosynthesis, directly binds to and inactivates MarR, the key 
regulator of the marRAB operon involved in antibiotic resistance. Whether arabinose and other 
sugars activate the MDR regulators is not known though it is an intriguing hypothesis 
nonetheless. 
We conclude by noting that sugar efflux may be a novel target for metabolic engineering. 
Clearly, one way to increase metabolic flux for the production of biofuels and other valuable 
chemicals is to remove sugar efflux. As previously mentioned, the present work was motivated 
by looking at novel targets for optimizing pentose metabolism in E. coli. Whether sugar efflux 
transporters provide a viable target for metabolic engineering is not known, but it does provide a 
totally unexplored area that clearly merits further investigation. 
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2.5 Figures and tables 
Table 2.1. List of candidate efflux transporter genes. 
Gene Annotation 
  
setA broad specificity sugar efflux system 
setB lactose/glucose efflux system 
setC predicted sugar efflux system 
ydeA sugar efflux transporter 
mhpT putative 3-hydroxyphenylpropionic acid transporter 
yajR putative transporter 
ybdA (entS) predicted transporter 
cmr (mdfA) multidrug efflux system protein 
ycaD putative MFS family transporter 
yceL orf, hypothetical protein 
ydeE predicted transporter 
ynfM predicted transporter 
ydhP predicted transporter 
mdtG (yceE) predicted drug efflux system 
yebQ putative transporter 
shiA shikimate transporter 
mdtD (yegB) multidrug efflux system protein 
bcr bicyclomycin/multidrug efflux system 
yfcJ predicted transporter 
kgtP alpha-ketoglutarate transporter 
ygcS putative transporter 
galP D-galactose transporter 
nanT sialic acid transporter 
yhhS putative transporter 
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Table 2.1 (cont.) 
Gene Annotation 
  
nepI (yicM) predicted transporter 
emrD 2-module integral membrane pump; multidrug resistance 
mdtL (yidY) multidrug efflux system protein 
proP proline/glycine betaine transporter 
yjhB putative transporter 
yjiO (mdtM) multidrug efflux system protein 
ydhC predicted transporter 
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Table 2.2. Bacterial strains used in this work. 
Strain Genotype or relevant characteristics
a Source or 
reference
b,c 
   
MG1655 F
-
 λ
-
 ilvG rph-1 CGSC #7740 
DH5α 
phi-80d lac∆m15 enda1 recA1 hsdR17 supE44 thh-1 gyrA96 
relA∆lacU169 
New England 
Biolabs 
CR400 ∆araA::kan 56 
CR401 ∆araB::kan 56 
CR404 ∆araBAD::kan 56 
CR701 ∆tolC::cat 86 
CR702 ∆tolC::FRT 86 
CR1100 ∆setA:: FRT kan FRT (77621-78799)  
CR1101 ∆setB:: FRT kan FRT (2261885-2263066)  
CR1102 ∆setC:: FRT kan FRT (3834976-3836160)  
CR1103 ∆ydeA:: FRT kan FRT (1615052-1616242)  
CR1104 ∆mhpT:: FRT kan FRT (374683-375894)  
CR1105 ∆yajR:: FRT kan FRT (444526-445890)  
CR1106 ∆ybdA::FRT kan FRT (621523-622773)  
CR1107 ∆cmr::FRT kan FRT (882896-884128)  
CR1108 ∆ycaD::FRT kan FRT (945094-946242)  
CR1109 ∆yceL::FRT kan FRT (1123341-1124549)  
CR1110 ∆ydeE::FRT kan FRT (1619356-1620543)  
CR1111 ∆ynfM::FRT kan FRT (1667723-1668976)  
CR1112 ∆ydhP::FRT kan FRT (1734145-1735314)  
CR1113 ∆mdtG::FRT kan FRT (1113487-1114713)  
CR1114 ∆yebQ::FRT kan FRT (1908300-1909673)  
CR1115 ∆shiA::FRT kan FRT (2051667-2052983)  
CR1116 ∆mdtD::FRT kan FRT (2159488-2160903)  
CR1117 ∆bcr::FRT kan FRT (2276592-2277782)  
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Table 2.2 (cont.) 
Strain Genotype or relevant characteristics
a Source or 
reference
b,c 
   
CR1118 ∆yfcJ::FRT kan FRT (2436964-2438142)  
CR1119 ∆kgtP::FRT kan FRT (2722470-2723768)  
CR1120 ∆ygcS::FRT kan FRT (2894555-2895892)  
CR1121 ∆galP::FRT kan FRT (3086306-3087700)  
CR1122 ∆nanT::FRT kan FRT (3369106-3370596)  
CR1123 ∆yhhS::FRT kan FRT (3608539-3609756)  
CR1124 ∆nepI::FRT kan FRT (3838572-3839762)  
CR1125 ∆emrD::FRT kan FRT (3851945-3853129)  
CR1126 ∆mdtL::FRT kan FRT (3889638-3890813)  
CR1127 ∆proP::FRT kan FRT (4328525-4330027)  
CR1128 ∆yjhB::FRT kan FRT (4502081-4503298)  
CR1129 ∆yjiO::FRT kan FRT (4565310-4566542)  
CR1130 ∆ydhC::FRT kan FRT (1737935-1739146)  
CR1131 ∆setA::FRT  
CR1132 ∆setB::FRT   
CR1133 ∆setC::FRT   
CR1134 ∆ydeA::FRT   
CR1135 ∆mhpT::FRT   
CR1136 ∆yajR::FRT   
CR1137 ∆ybdA::FRT   
CR1138 ∆cmr::FRT   
CR1139 ∆ycaD::FRT   
CR1140 ∆yceL::FRT   
CR1141 ∆ydeE::FRT   
CR1142 ∆ynfM::FRT   
CR1143 ∆ydhP::FRT   
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Table 2.2 (cont.) 
Strain Genotype or relevant characteristics
a Source or 
reference
b,c 
   
CR1144 ∆mdtG::FRT   
CR1145 ∆yebQ::FRT   
CR1146 ∆shiA::FRT   
CR1147 ∆mdtD::FRT   
CR1148 ∆bcr::FRT   
CR1149 ∆yfcJ::FRT   
CR1150 ∆kgtP::FRT   
CR1151 ∆ygcS::FRT   
CR1152 ∆galP::FRT   
CR1153 ∆nanT::FRT   
CR1154 ∆yhhS::FRT   
CR1155 ∆nepI::FRT   
CR1156 ∆emrD::FRT   
CR1157 ∆mdtL::FRT   
CR1158 ∆proP::FRT   
CR1159 ∆yjhB::FRT   
CR1160 ∆yjiO::FRT   
CR1161 ∆ydhC::FRT   
CR1162 ∆setC::FRT ∆araA::FRT  
CR1163 ∆cmr::FRT ∆araA::FRT  
CR1164 ∆ynfM::FRT ∆araA::FRT  
CR1165 ∆ydhP::FRT ∆araA::FRT  
CR1166 ∆mdtD::FRT ∆araA::FRT  
CR1167 ∆yfcJ::FRT ∆araA::FRT  
CR1168 ∆yhhS::FRT ∆araA::FRT 
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Table 2.2 (cont.) 
Strain Genotype or relevant characteristics
a Source or 
reference
b,c 
   
CR1169 ∆emrD::FRT ∆araA::FRT  
CR1170 ∆ydhC::FRT ∆araA::FRT  
CR1171 ∆setC::FRT ∆araB::FRT  
CR1172 ∆cmr::FRT ∆araB::FRT  
CR1173 ∆ynfM::FRT ∆araB::FRT  
CR1174 ∆mdtD::FRT ∆araB::FRT  
CR1175 ∆yfcJ::FRT ∆araB::FRT  
CR1176 ∆yhhS::FRT ∆araB::FRT  
CR1177 ∆emrD::FRT ∆araB::FRT  
CR1178 ∆ydhC::FRT ∆araB::FRT  
CR1179 ∆setC::FRT ∆araBAD::FRT  
CR1180 ∆cmr::FRT ∆araBAD::FRT  
CR1181 ∆ynfM::FRT ∆araBAD::FRT  
CR1182 ∆mdtD::FRT ∆araBAD::FRT  
CR1183 ∆yfcJ::FRT ∆araBAD::FRT  
CR1184 ∆yhhS::FRT ∆araBAD::FRT  
CR1185 ∆emrD::FRT ∆araBAD::FRT  
CR1186 ∆ydhC::FRT ∆araBAD::FRT  
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Table 2.3. Plasmids used in this work. 
Plasmids Genotype or relevant characteristics
a
 
Source or 
reference
b,c
 
   
pKD46 bla PBAD gam bet exo pSC101 ori(ts) 73 
pCP20 bla cat cI857 λPR’-flp pSC101 ori(ts) 91 
pKD3 
bla FRT cm FRT oriR6K 
73 
pKD4 bla FRT kan FRT oriR6K 73 
pPROBE venus kan venus ori p15a  
pTrc99A amp Ptrc ori (pBR322) lacl
q
 76 
ParaB-venus kan ParaB-venus ori p15a  
PxylA-venus kan PxylA-venus ori p15a  
pKK001 (pSetA) amp Ptrc setA ori (pBR322) lacl
q
  
pKK002 (pSetB) amp Ptrc setB ori (pBR322) lacl
q
  
pKK003 (pSetC) amp Ptrc setC ori (pBR322) lacl
q
  
pKK004 (pYdeA) amp Ptrc setA ori (pBR322) lacl
q
  
pKK005 (pMhpT) amp Ptrc mhpT ori (pBR322) lacl
q
  
pKK006 (pYajR) amp Ptrc yajR ori (pBR322) lacl
q
  
pKK007 (pYbdA) amp Ptrc ybdA ori (pBR322) lacl
q
  
pKK008 (pCmr) amp Ptrc cmr ori (pBR322) lacl
q
  
pKK009 (pYcaD) amp Ptrc ycaD ori (pBR322) lacl
q
  
pKK010 (pYceL) amp Ptrc yceL ori (pBR322) lacl
q
  
pKK011 (pYdeE) amp Ptrc ydeE ori (pBR322) lacl
q
  
pKK012 (pYnfM) amp Ptrc ynfM ori (pBR322) lacl
q
  
pKK013 (pYdhP) amp Ptrc ydhP ori (pBR322) lacl
q
  
pKK014 (pMdtG) amp Ptrc mdtG ori (pBR322) lacl
q
  
pKK015 (pYebQ) amp Ptrc yebQ ori (pBR322) lacl
q
  
pKK016 (pShiA) amp Ptrc shiA ori (pBR322) lacl
q
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Table 2.3 (cont.) 
Plasmids Genotype or relevant characteristics
a
 
Source or 
reference
b,c
 
   
pKK017 (pMdtD) amp Ptrc mdtD ori (pBR322) lacl
q
  
pKK018 (pBcr) amp Ptrc bcr ori (pBR322) lacl
q
  
pKK019 (pYfcJ) amp Ptrc yfcJ ori (pBR322) lacl
q
  
pKK020 (pKgtP) amp Ptrc kgtP ori (pBR322) lacl
q
  
pKK021 (pYgcS) amp Ptrc ygcS ori (pBR322) lacl
q
  
pKK022 (pGalP) amp Ptrc galP ori (pBR322) lacl
q
  
pKK023 (pNanT) amp Ptrc nanT ori (pBR322) lacl
q
  
pKK024 (pYhhS) amp Ptrc yhhS ori (pBR322) lacl
q
  
pKK025 (pNepI) amp Ptrc nepI ori (pBR322) lacl
q
  
pKK026 (pEmrD) amp Ptrc emrD ori (pBR322) lacl
q
  
pKK027 (pMdtL) amp Ptrc mdtL ori (pBR322) lacl
q
  
pKK028 (pProp) amp Ptrc proP ori (pBR322) lacl
q
  
pKK029 (pYjhB) amp Ptrc yjhB ori (pBR322) lacl
q
  
pKK031 (pYjiO) amp Ptrc yjiO ori (pBR322) lacl
q
  
pKK032 (pYdhC) amp Ptrc ydhC ori (pBR322) lacl
q
  
pKK033 (PsetC-venus) kan PsetC-venus ori p15a  
pKK034 (PydeA-venus) kan PydeA-venus ori p15a  
pKK035 (PmhpT-venus) kan PmhpT-venus ori p15a  
pKK036 (PybdA-venus) kan PybdA-venus ori p15a  
pKK037 (PydeE-venus) kan PydeE-venus ori p15a  
pKK038 (PkgtP-venus) kan PkgtP-venus ori p15a  
pKK039 (Pcmr-venus) kan Pcmr-venus ori p15a  
pKK040 (PynfM-venus) kan PynfM-venus ori p15a  
pKK041 (PmdtD-venus) kan PmdtD-venus ori p15a  
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Table 2.3 (cont.) 
Plasmids Genotype or relevant characteristics
a
 
Source or 
reference
b,c
 
   
pKK042 (PyfcJ-venus) kan PyfcJ-venus ori p15a  
pKK043 (PyhhS-venus) kan PyhhS-venus ori p15a  
pKK044 (PemrD-venus) kan PemrD-venus ori p15a  
pKK045 (PydhC-venus) kan PydhC-venus ori p15a  
 
a. All strains are isogenic derivatives of E. coli K-12 strain MG1655. 
b. All strains and plasmids are from this work unless otherwise noted. 
c. E. coli Genetic Stock Center, CGSC, Yale University. 
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Table 2.4. Primers used for gene deletions 
Efflux 
Transporter 
Gene 
Primer Sequence 
setA 
KK016f 
ATG ATC TGG ATA ATG ACG ATG GCT CGC CGT ATG AAC GGT GGT GTA 
GGC TGG AGC TGC TTC 
KK016r 
TCA AAC GTC TTT AAC CTT TGC GGT TAA AAA TAA TGC GAC ACA TAT GAA 
TAT CCT CCT TAG 
setC 
KK018f 
ATG CAA AAA ACG GCT ACC ACT CCA TCA AAA ATA CTT GAT CGT GTA 
GGC TGG AGC TGC TTC 
KK018r 
CTA AAT ATC TTT AAT AAA CAG CAG GCA AAT CAT CGC AAT ACA TAT GAA 
TAT CCT CCT TAG 
ydeA 
TD139f 
TCA TTT CAT CAC TTT TTC GCA ACT CAC CCG ATA ATC TGT TGT GTA GGC 
TGG AGC TGC TTC 
TD139r 
ACT ATT GCG TCT GTT CTT CGA GTG CAC TGG CCA GCG GCG CA TAT 
GAA TAT CCT CCT TAG 
mhpT 
KK030f 
ATG TCG ACT CGT ACC CCT TCA TCA TCT TCA TCC CGC CTG AGT GTA 
GGC TGG AGC TGC TTC 
KK030r 
TCA GGC ATC GGC GCA CGG CTG TAT TCG TGA TCT CCG GCT CCA TAT 
GAA TAT CCT CCT TAG 
yajR 
KK032f 
ATG AAC GAT TAT AAA ATG ACG CCA GGT GAG AGG CGC GCG AGT GTA 
GGC TGG AGC TGC TTC 
KK032r 
TTA TGC CTG ACG AAT TGC CTG TTC TAT CTC AAA GCG ATT CCA TAT GAA 
TAT CCT CCT TAG 
ybdA 
KK034f 
ATG AAT AAA CAA TCC TGG CTG CTT AAC CTC AGC CTG TTG AGT GTA 
GGC TGG AGC TGC TTC 
KK034r 
TTA ACT GTC GGA CGC TGT CAC CTG CGG CGG CGT CTG GCG ACA TAT 
GAA TAT CCT CCT TAG 
cmr 
KK036f 
ATG CAA AAT AAA TTA GCT TCC GGT GCC AGG CTT GGA CGT CGT GTA 
GGC TGG AGC TGC TTC 
KK036r 
TTA CCC TTC GTG AGA ATT TCC CAT CTG TTT ATC TTT TAA ACA TAT GAA 
TAT CCT CCT TAG 
ycaD 
KK038f 
ATG TCC ACG TAT ACC CAG CCT GTC ATG CTT TTG CTG TCT GGT GTA 
GGC TGG AGC TGC TTC 
KK038r 
TTA CAC GTG AGC AAC GGG TTT CGG CGT ATG ACC GGC GTT GCA TAT 
GAA TAT CCT CCT TAG 
yceL 
KK053f 
ATG TCC CGC GTG TCG CAG GCG AGG AAC CTG GGT AAA TAT TGT GTA 
GGC TGG AGC TGC TTC 
KK053r 
TCA GGC GTC GCG TTC AAG CAA ACG ACG CGC GGC GCG TTT CCA TAT 
GAA TAT CCT CCT TAG 
ydeE 
KK055f 
ATG AAC TTA TCC CTA CGA CGC TCT ACC AGC GCC CTT CTT GGT GTA 
GGC TGG AGC TGC TTC 
KK055r 
TCA ACA AAG CGC GGG CTG CCC CCA CGG TCT TGC TCG AAT CCA TAT 
GAA TAT CCT CCT TAG 
ynfM 
KK057f 
GTG AGC CGT ACT ACA ACT GTT GAT GGC GCT CCG GCA AGC GGT GTA 
GGC TGG AGC TGC TTC 
KK057r 
TCA GGC GTG CAG ACG ACG ATG CAA ACG CGT CCC GAC CAG CCA TAT 
GAA TAT CCT CCT TAG 
ydhP 
 
 
KK059f 
ATG AAA ATT AAC TAT CCG TTG CTG GCG CTG GCG ATT GGC GGT GTA 
GGC TGG AGC TGC TTC 
KK059r 
TTA GCT GTT AGC AAC GCA AAC TGT TTC AGG TTG TTT TCT GCA TAT GAA 
TAT CCT CCT TAG 
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Table 2.4 (cont.) 
mdtG 
KK061f 
ATG TCA CCC TGT GAA AAT GAC ACC CCT ATA AAC TGG AAA CGT GTA 
GGC TGG AGC TGC TTC 
KK061r 
TCA GTT CGA TAC CTG GGG TAT TCG ACG ACG ACG TAG ACT GCA TAT 
GAA TAT CCT CCT TAG 
yebQ 
KK063f 
ATG CCA AAA GTT CAG GCC GAC GGC CTG CCA TTG CCC CAG CGT GTA 
GGC TGG AGC TGC TTC 
KK063r 
TTA TGC CCT GGA TCG TGG CTG AGT GAT ACG TAA ACC ACT GCA TAT 
GAA TAT CCT CCT TAG 
shiA 
KK065f 
ATG GAC TCC ACG CTC ATC TCC ACT CGT CCC GAT GAA GGG AGT GTA 
GGC TGG AGC TGC TTC 
KK065r 
TCA AGC GCG TTG ACT GTC TTT CAT CAA CAA AGC GGT CAT TCA TAT 
GAA TAT CCT CCT TAG 
mdtD 
KK067f 
ATG ACA GAT CTT CCC GAC AGC ACC CGT TGG CAA TTG TGG AGT GTA 
GGC TGG AGC TGC TTC 
KK067r 
TCA TTG CGC GCT CCT TTT TCG CCG CGA AAT AGC TAC ATT TCA TAT 
GAA TAT CCT CCT TAG 
setB 
KK069f 
ATG CAT AAC TCC CCC GCA GTC TCC AGC GCG AAA TCG TTT GGT GTA 
GGC TGG AGC TGC TTC 
KK069r 
TTA AAC ATC TTT AAT CCG CAG TAA GCA AAA CAG AGT GGC GCA TAT 
GAA TAT CCT CCT TAG 
bcr 
KK071f 
GTG ACC ACC CGA CAG CAT TCG TCG TTT GCT ATT GTT TTT AGT GTA 
GGC TGG AGC TGC TTC 
KK071r 
TCA CCG TTT TTT CGG CCG ACT GGC GTA CAG ACA GAA GAG ACA TAT 
GAA TAT CCT CCT TAG 
yfcJ 
KK073f 
ATG ACT GCT GTA AGC CAA ACC GAA ACA CGA TCT TCT GCC AGT GTA 
GGC TGG AGC TGC TTC 
KK073r 
TTA ACC CCG ACG AAA TGA CAG TAT CGT GAC AAT AAT ACC CCA TAT 
GAA TAT CCT CCT TAG 
kgtP 
KK075f 
ATG GCT GAA AGT ACT GTA ACG GCA GAC AGC AAA CTG ACA AGT GTA 
GGC TGG AGC TGC TTC 
KK075r 
CTA AAG ACG CAT CCC CTT CCC TTT GCG ATG TAG CAT CAA ACA TAT 
GAA TAT CCT CCT TAG 
ygcS 
KK077f 
ATG AAC ACT TCA CCG GTG CGA ATG GAT GAT TTA CCG CTT AGT GTA 
GGC TGG AGC TGC TTC 
KK077r 
TTA AAC GCT AAC AGA ATG TTC ATT CGC ACC TCC TAC ATTT CA TAT GAA 
TAT CCT CCT TAG 
galP 
KK081f 
ATG CCT GAC GCT AAA AAA CAG GGG CGG TCA AAC AAG GCA AGT GTA 
GGC TGG AGC TGC TTC 
KK081r 
TTA ATC GTG AGC GCC TAT TTC GCG CAG TTT ACG ACC TTT CCA TAT 
GAA TAT CCT CCT TAG 
nanT 
KK083f 
ATG AGT ACT ACA ACC CAG AAT ATC CCG TGG TAT CGC CAT CGT GTA 
GGC TGG AGC TGC TTC 
KK083r 
TTA ACT TTT GGT TTT GAC TAA ATC GTT TTT GGC GCT GCC ACA TAT GAA 
TAT CCT CCT TAG 
yhhS 
KK085f 
ATG CCC GAA CCC GTA GCC GAA CCC GCG CTA AAC GGA TTG CGT GTA 
GGC TGG AGC TGC TTC 
KK085r 
TTA AGA TGA TGA GGC GGC CTC AGG GAC GTG TTC CGG AGG CCA TAT 
GAA TAT CCT CCT TAG 
nepI 
KK087f 
ATG AGT GAA TTT ATT GCC GAA  AAC CGC GGC GCG GAT GCC AGT GTA 
GGC TGG AGC TGC TTC 
KK087r 
TCA GGA TTT CTT CAT TTT CAC CTT TGC AGT AAC CAA CAA TCA TAT GAA 
TAT CCT CCT TAG 
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Table 2.4 (cont.) 
 
emrD 
KK089f 
ATG AAA AGG CAA AGA AAC GTC AAT TTG TTA TTG ATG TTG GGT GTA 
GGC TGG AGC TGC TTC 
KK089r 
TTA AAC GGG CTG CCC CTG ATG CGA CAT CCG CGT CGC CAG CCA TAT 
GAA TAT CCT CCT TAG 
mdtL 
KK091f 
ATG TCC CGC TTT TTG ATT TGT AGT TTT GCC CTG GTT TTA CGT GTA GGC 
TGG AGC TGC TTC 
KK091r 
TCA AGC GTG GTG ATG GAT TTC TTC ATG AGC GGC AAC GGG GCA TAT 
GAA TAT CCT CCT TAG 
proP 
KK093f 
ATG CTG AAA AGG AAA AAA GTA AAA CCG ATT ACC CTT CGT GGT GTA 
GGC TGG AGC TGC TTC 
KK093r 
TTA TTC ATC AAT TCG CGG ATG TTG CTG CAC CAG GCG GGT ACA TAT 
GAA TAT CCT CCT TAG 
yjhB 
KK095f 
ATG GCA ACA GCA TGG TAT AAA CAA GTT AAT CCA CCA CAA CGT GTA 
GGC TGG AGC TGC TTC 
KK095r 
TCA TTT AGC CAC GGA TAG TTT ATA AAT TTT ACC TGG AAT ACA TAT GAA 
TAT CCT CCT TAG 
yjiO 
KK097f 
ATG CCA CGT TTT TTT ACC CGC CAT GCC GCC ACG CTG TTT TGT GTA 
GGC TGG AGC TGC TTC 
KK097r 
TCA CTG CTC CTC CAC TAG CTC GGC TGC CTG ATG CTG GCG CCA TAT 
GAA TAT CCT CCT TAG 
ydhC 
KK099f 
ATG CAA CCT GGG AAA AGA TTT TTA GTC TGG CTG GCG GGT TGT GTA 
GGC TGG AGC TGC TTC 
KK099r 
TCA GTG TGA TTC GCT ATG AGC GAC TTC GGC ATT GCC ATG ACA TAT 
GAA TAT CCT CCT TAG 
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Table 2.5. Knockout check primers 
Efflux 
Transporter 
Gene 
Primer Sequence 
setA 
KK017f CGC CAG CAG ATT ATA CCT GC 
KK017r GCT TTC CGC TAT CGT CCA CG 
setC 
KK019f TTC GCC CGG TGA TTC AGA AG 
KK019r TGG CTC TGT TTG CGC CAC GC 
ydeA 
TD140f AAT TAT CAA ACA TAT GGC GC 
TD140r TGT GCT CGC TTC CCG GCC GG 
mhpT 
KK031f CAC CTG CAC TCG CAA CGA GG 
KK031r TCG GCG CAC GGC TGT ATT CG 
yajR 
KK033f GCA GCA GGC AAT TCG CCG CG 
KK033r CAC TGC GGC CAG CAT TGC G C 
ybdA 
KK035f ATG TGC AGC CTA AGA ATA GG 
KK035r CGC CTA AAA TCC ACA TCG GC 
cmr 
KK037f CTG CGC GAT TAT TAT TGG CG 
KK037r TGC AGC ATT CCC ATC GCG GC 
ycaD 
KK039f TTG GCG GTG GCA TGA TGC GC 
KK039r CTT TCT CGC AAG CCC ATG CC 
yceL 
KK054f AAC TCT CTA TCA AAG CGA CG 
KK054r GGC AGT AAG GGC AGT GAT CG 
ydeE 
KK056f TAG TCG CCG GTT ACG ACG GC 
KK056r GGT GTG TTT CCT CGC TTA CC 
ynfM 
KK058f ACA AAG TAA CGC AGA TGA CG 
KK058r CTG CGG GAA TTG GCT GGC GC 
ydhP 
KK060f TCT CCT TCC TGT TTG TTA GC 
KK060r CGA TGT AGG TCG GAT AAG GC 
mdtG 
KK062f AGC TCT CTG GAT TGC GCC CC 
KK062r TTG CGT ACA TGG TCA TCA CG 
yebQ 
KK064f TTT CGC ACC AGG GTG GTC GC 
KK064r CAC CCG CCG CTG GAT AAA CG 
shiA 
KK066f GTC GAG GTA GTC TCA TAA GG 
KK066r TCA TGT GTG TCT CCT GTT CC 
mdtD 
KK068f AGC TCC TTA CGC TGT ATA CC 
KK068r AAA ACT GAT ACG CAC CGC CC 
setB 
KK070f GGC ATT TTG ACT ATT CGT GG 
KK070r CGA CCG AAA GTC TGT GCA GG 
bcr 
KK072f CGC TGG ATG CTG ATT TAG CC 
KK072r GGG GAA TGA TAG ATT TGT GG 
yfcJ 
KK074f AAG ACG TAC GCG TTA AAT CC 
KK074r TTC CAC CGA TGA TGG ACA CG 
kgtP 
KK076f CCT GCT AAC TAA ATT CAT GG 
KK076r GGG ATA GCC GCC CCG AAG GG 
ygcS 
KK078f TAA TGT GTC AGG CAG CGT TCC 
KK078r CGA GTA AAC TTC GCA GTA GC 
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Table 2.5 (cont.) 
galP 
KK082f GAT AAA TGT TAG TGT AAG CG 
KK082r GAT GGC GAT AGG GAG ACG GG 
nanT 
KK084f CCC TCG CTC GCC CCT ACC GG 
KK084r ATC AGG CCA CCG TTA GCA GC 
yhhS 
KK086f GTA GCG GGA GTC ACG CCA GC 
KK086r TAA TCA ACT GCT GAC CAT GC 
nepI 
KK088f AGC AAC ACC GTA AAA GTT GC 
KK088r TTG GGA AGC GTT GGG TAA GG 
emrD 
KK090f ATT CCT GGC GTA TAT CTG GC 
KK090r TTA TTC TTA CTC CGC ACC GC 
mdtL 
KK092f CTT GCC TCT CAG GAA ATC AC 
KK092r GAC TTA CTC ACC GCC GAA GG 
proP 
KK094f TTG CAT CCT GCA ATT CCC GC 
KK094r CCT GGA GGA GAG TAT GCG CG 
yjhB 
KK096f GTA CTG GCG TAT TTG AAG AC 
KK096r AAA CGA GCT AAT TCA GCG CC 
yjiO 
KK098f CAT TTG CAG TCT CGT TGC CC 
KK098r TAA GCA GTA AAG AGA GCG CC 
ydhC 
KK100f TGA CCA CAT AGT CTG CCT GC 
KK100r TCG AAA TTA GTA TAG GCC GC 
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Table 2.6. Primers used to amplify efflux transporter promoters. 
Efflux 
Transporter 
Gene 
Primer Promoter Sequence Region 
Amplified 
setC 
KK165f ATC GGT ACC ATA TAT CAA ATC AAC TTG TT 
3834726-3834975 
KK165r ATC GAA TTC TCT TCT GAA TCA CCG GGC GA 
ydeA 
KK166f ATC GGT ACC AAC CGT GAT GTT ACC GAC TC 
1614902-1615051 
KK166r ATC GAA TTC AAC AGA TTA TCG GGT GAG TT 
mhpT 
KK167fii ATC GGT ACC GAA CGT GCA TTT TGT ATG CC 
374119-374682 
KK167r ATC GAA TTC AAG ATG AAC CTC GTT GCG AG 
ybdA 
KK168fi ATC GGT ACC AAC TTC CAT GAT AAT GAA AT 
621416-621522 
KK168r ATC GAA TTC TAC AAT GCC TTG CCA TCA AA 
cmr 
KK171f ATC GGT ACC GGC ATAG GTTA AAT AAA ACT 
882746-882895 
KK171r ATC GAA TTC GCA ATT TCT TCG CCA ATA AT 
ydeE 
KK169f ATC GGT ACC CCG CCT CTG AAT TTC ATC TT 
1619166-1619355 
KK169r ATC GAA TTC TTG TCT GTC CGG CAG TGC GT 
ynfM 
KK172f ATC GGT ACC AAC ATC TTA TTT GAG ATT AT 
1667623-1667722 
KK172r ATC GAA TTC TTG AAA TCC TTG CTA AAT AT 
mdtD 
KK173f ATC GGT ACC TGT CTG CTG CGT TTT CGC CC 
2159248-2159487 
KK173r ATC GAA TTC TTA CTC GGT TAC CGT TTG TT 
kgtP 
KK170f ATC GGT ACC CTG CGC GTC TTA TAC TCC CA 
2722220-2722469 
KK170r ATC GAA TTC GCC ATT ATG TCT CCT GCC GT 
yfcJ 
KK174f ATC GGT ACC AGT TCC AGG CAA ACT TCC CG 
2436824-2436963 
KK174r ATC GAA TTC GCA TTA CTC CAG AAT GCA GC 
yhhS 
KK175f ATC GGT ACC ATT AAG TGT AGC GGG AGT CA 
3608432-3608588 
KK175r ATC GAA TTC AAA TTC AGG CGC AAT CCG TT 
emrD 
KK176f ATC GGT ACC GGG AAA CCG CTC CCC TTT TA 
3851695-3851944 
KK176r ATC GAA TTC TAT CAC GGA TGC TTT TAT AA 
ydhC 
KK177f ATC GGT ACC AAA TTT TTG AAA CCA GTC AT 
1737835-1737934 
KK177r ATC GAA TTC GTA TAT TCT CTA AAT CTC TC 
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Table 2.7. Primers used to amplify efflux transporter genes. 
Efflux 
Transporter 
Gene 
Primer Sequence 
setA 
KK040f ATC GGT ACC GCC GCG CTA AAA AGG GAA CG  
KK040r ATC GGA TCC GCT TTC CGC TAT CGT CCA CG 
setC 
KK026f ATC GGT ACC ATG CAA AAA ACG GCT ACC ACT CC 
KK026r ATC GGA TCC CCC AGA CTG GTG AGC TAA ATA TC 
ydeA 
KK013f ATC GGT ACC ATT AAA CCG TGA TGT TAC CG 
KK014r ATC GGA TCC TGG GCC TTT CAA CTA TTG CG 
mhpT 
KK048f ATC GGT ACC CTT ATG TCG ACT CGT ACC CC 
KK048r ATC GGA TCC AAG GCA CGT CAG GCA TCG GC 
yajR 
KK049f ATC GGT ACC AAC AGA GGT GGT AAT GAA CG 
KK049r ATC GGA TCC TTA TGC CTG ACG AAT TGC C 
ybdA 
KK050f ATC GGT ACC GCA TGT GCA GCC TAA GAA TAG G 
KK050r ATC GGA TCC TTA ACT GTC GGA CGC TGT CAC C 
cmr 
KK143f ATC GAA TTC TTG GCG AAG AAA TTG CAT GC 
KK143r ATC GGT ACC TTA CCC TTC GTG AGA ATT TCC 
ycaD 
KK052f ATC GGT ACC ATG TCC ACG TAT ACC CAG CC 
KK052r ATC GGA TCC ATT TAC ACG TGA GCA ACG GG 
yceL 
KK119f ATC GGT ACC ATG TCC CGC GTG TCG CAG GC 
KK119r ATC GGA TCC ATC AGG CGT CGC GTT CAA GC 
ydeE 
KK120f ATC GGT ACC ATG AAC TTA TCC CTA CGA CG 
KK120r ATC GGA TCC TCA ACA AAG CGC GGG CTG CC 
ynfM 
KK121f ATC GGT ACC CAA GGA TTT CAA GTG AGC CG 
KK121r ATC GGA TCC TTT CAG GCG TGC AGA CGA CG 
ydhP 
KK122f ATC GGT ACC GCA TGA AAA TTA ACT ATC CG 
KK122r ATC GGA TCC TAA TTA GCT GTT AGC AAC GC 
mdtG 
KK118f ATC GGT ACC AGC GGA TTG CTA TGT CAC CC 
KK118r ATC GGA TCC AAT CAG TTC GAT ACC TGG GG 
yebQ 
KK123f ATC GGT ACC TAT GCC AAA AGT TCA GGC CG 
KK123r ATC GGA TCC TTT ATG CCC TGG ATC GTG GC 
shiA 
KK124f ATC GGT ACC ATG GAC TCC ACG CTC ATC TCC 
KK124r ATC GGA TCC TCG CCA GGC TAT CAA GCG CG 
mdtD 
KK125f ATC GGT ACC GTA AAT GAC AGA TCT TCC CG 
KK125r ATC GGA TCC TCA TTG CGC GCT CCT TTT TCG 
setB 
KK126f ATC GGT ACC AGC ATG CAT AAC TCC CCC GC 
KK126r ATC GGA TCC CTT AAA CAT CTT TAA TCC GC 
bcr 
KK146f ATC GAA  TTC GTG ACC ACC CGA CAG CAT TCG 
KK146r ATC GGT ACC AGA TCA CCG TTT TTT CGG CCG 
yfcJ 
KK103f ATC GGT ACC ATG ACT GCT GTA AGC CAA ACC 
KK103r ATC GGA TCC CTG GTT CGT TAA CCC CGA CG 
kgtP 
KK104f ATC GGT ACC ATG GCT GAA AGT ACT GTA ACG 
KK104r ATC GGA TCC CTA AAG ACG CAT CCC CTT CCC 
ygcS 
KK105f ATC GGT ACC ATG AAC ACT TCA CCG GTG CG 
KK105r ATC GGA TCC TCC GGT TCG GCT TTA AAC GC 
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Table 2.7 (cont.) 
galP 
KK144f ATC GAG CTC ATG CCT GAC GCT AAA AAA CAG G 
KK144r ATC TCT AGA TTA ATC GTG AGC GCC TAT TTC GC 
nanT 
KK108f ATC GGT ACC TCA CAA TGA GTA CTA CAA CC 
KK108r ATC GGA TCC GCA ACA GGA TTA ACT TTT GG 
yhhS 
KK109f ATC GGT ACC CAT GCC CGA ACC CGT AGC CG 
KK109r ATC GGA TCC TTT AAG ATG ATG AGG CGG CC 
nepI 
KK110f ATC GGT ACC CAT GAG TGA ATT TAT TGC CG 
KK110r ATC GGA TCC TCA GGA TTT CTT CAT TTT CAC C 
emrD 
KK145f ATC GAA TTC ATC CGT GAT AAT GAA AAG GC 
KK145r ATC GGT ACC AAC GGG CTG CCC CTG ATG CG 
mdtL 
KK112f ATC GGT ACC CGC TTT AGC CCA TGT CCC GC 
KK112r ATC GGA TCC GAG ATC AAG CGT GGT GAT GG 
proP 
KK113f ATC GGT ACC GGA AAG CTA TGC TGA AAA GG 
KK113r ATC GGA TCC GCT TAT TCA TCA ATT CGC GG 
yjhB 
KK114f ATC GGT ACC CAA ATA TGG CAA CAG CAT GG 
KK114r ATC GGA TCC CTC CAA TCA TTT AGC CAC GG 
yjiO 
KK115f ATC GGT ACC ATG CCA CGT TTT TTT ACC CGC 
KK115r ATC GGA TCC CAC TGC TCC TCC ACT AGC TCG 
ydhC 
KK116f ATC GGT ACC GAA TAT ACA TGC AAC CTG GG 
KK116r ATC GGA TCC TCA GTG TGA TTC GCT ATG AGC 
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Table 2.8. KM and Vmax values
*. 
Efflux transporter deletions   Efflux transporter overexpressions 
Gene KM Vmax x 10
4           Gene 2 mM 
IPTG 
0.2 mM 
IPTG 
              
          KM Vmax x 10
4 KM Vmax x 10
4 
Control 3.17 6.88       Control 2.73 11.1 2.84 11.9 
setC 3.51 12.7       setC Growth defect 5.27 6.49 
cmr 3.94 13.2       ydeE Growth defect 4.10 7.59 
ynfM 3.77 12.3       ydeA 3.11 4.53 No effect 
mdtD 4.17 13.8       kgtP 2.75 7.65 No effect 
yfcJ 3.04 9.96       mhpT 0.345 7.08 1.35 7.47 
yhhS 4.96 14.8       ybdA 0.933 6.84 1.33 7.93 
emrD 3.61 12.6            
ydhC 3.82 12.4            
 
*KM values are reported in mM 
Vmax values are reported as Fluorescence/OD600 
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Table 2.9. Summary of results. 
Efflux 
transporter 
Deletion effect? 
Overexpression 
effect? 
Effect on arabinose 
mutants 
TolC 
dependent? 
setC yes yes ΔaraA, ΔaraB, ΔaraBAD no 
cmr yes no not observed undetermined 
ynfM yes no not observed undetermined 
mdtD yes no not observed undetermined 
yfcJ yes no not observed undetermined 
yhhS yes no not observed undetermined 
emrD yes no not observed undetermined 
ydhC yes no not observed undetermined 
ydeE no yes ΔaraA, ΔaraB, ΔaraBAD yes 
ydeA no yes ΔaraA, ΔaraB, ΔaraBAD yes 
kgtP no yes ΔaraB yes 
mhpT no yes ΔaraB, ΔaraBAD no 
ybdA no yes ΔaraB, ΔaraBAD yes 
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Table 2.10. Sequence homology of identified putative efflux transporters to ydeA. 
Efflux transporter Homology to ydeA1,2 
setC 
59.2% identity in 76 nt overlap (66-141:34-108) 
65.2% identity in 69 nt overlap (232-298:238-301) 
58.4% identity in 125 nt overlap (735-852:1020-1143) 
cmr 
59.2% identity in 130 nt overlap (196-310:724-853) 
76.7% identity in 30 nt overlap (358-387:169-198) 
56.1% identity in 107 nt overlap (348-451:198-304) 
ynfM 
63.6% identity in 55 nt overlap (803-856:679-733) 
mdtD 
64.8% identity in 54 nt overlap (33-84:43-96) 
57.8% identity in 109 nt overlap (290-398:800-903) 
56.5% identity in 154 nt overlap (507-660:820-963) 
yfcJ 
54.5% identity in 202 nt overlap (693-886:111-307) 
yhhS 61.1% identity in 131 nt overlap (718-839:307-432) 
63.5% identity in 52 nt overlap (836-887:941-992) 
emrD 
68.6% identity in 51 nt overlap (844-892:919-967) 
ydhC 
No local region homology 
ydeE 
No local region homology 
kgtP 
59.5% identity in 84 nt overlap (184-266:468-548) 
62.5% identity in 88 nt overlap (223-303:460-547) 
63.9% identity in 61 nt overlap (691-750:793-853)  
mhpT 
59.7% identity in 77 nt overlap (933-1006:39-115) 
ybdA 
54.2% identity in 144 nt overlap (997-1136:679-821) 
 
1. Sequences were aligned and analyzed using William Pearson’s LALIGN program. The lalign 
program implements the algorithm of Huang and Miller, published in Adv. Appl. Math. (1991) 
12:337-357. Default settings of this program were used. 
2. The regions are reported as: sequence region of ydeA: sequence region of efflux transporter 
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Figure 2.1. Dose-response curve for the Δcmr mutant. ParaB-venus  in WT and Δcmr mutant strains 
were measured for fluorescence and the results are reported as Fluorescence/OD600. Strains were 
induced with arabinose concentrations varying from 0 mM to 10 mM.  
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Figure 2.2. Dose-response curve for ybdA+. ParaB-venus in WT and ybdA overexpressing strains were 
measured for fluorescence and the results are reported as Fluorescence/OD600. Strains were induced 
with arabinose concentrations varying from 0 mM to 10 mM. The ybdA overexpressing strain was induced 
with 2 mM IPTG. 
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Figure 2.3. Dose-response curve for ycaD+ induced with 2 mM IPTG. ParaB-venus in WT and ycaD 
overexpressing strains were measured for fluorescence and the results are reported as 
Fluorescence/OD600. Strains were induced with arabinose concentrations varying from 0 mM to 10 mM.  
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Figure 2.4. Dose-response curve for ycaD+ with no IPTG induction. ParaB-venus in WT and ycaD 
overexpressing strains were measured for fluorescence and the results are reported as 
Fluorescence/OD600. Strains were induced with arabinose concentrations varying from 0 mM to 10 mM.  
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Figure 2.5. Dose-response xylose curve for the ΔybdA mutant. PxylA-venus in WT and ΔybdA mutant 
strains were measured for fluorescence and the results are reported as Fluorescence/OD600. Strains were 
induced with xylose concentrations varying from 0 mM to 10 mM. 
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Figure 2.6. Dose-response xylose curve for mhpT+. PxylA-venus in WT and mhpT overexpressing 
strains were measured for fluorescence and the results are reported as Fluorescence/OD600. Strains were 
induced with xylose concentrations varying from 0 mM to 10 mM. The ybdA overexpressing strain was 
induced with 2 mM IPTG. 
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Figure 2.7. Deletion of the efflux transporters in arabinose mutants. The data is normalized to the 
relative fluorescence values of the control strains (ParaB-venus  in each of the individual arabinose 
mutants). All of the strains were induced with 5 mM arabinose. 
 
58 
 
 
Figure 2.8. Overexpression of the efflux transporters in arabinose mutants. The data is normalized to 
the relative fluorescence values of the control strains (ParaB-venus  and pTrc99A (empty plasmid) in each 
of the individual arabinose mutants). All of the strains were induced with 5 mM arabinose. 
Overexpression of the the efflux transporters was induced with 2 mM IPTG except for the 
overexpression of setC and ydeE where 0.2 mM IPTG was used.  
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Figure 2.9. Effect of deleting tolC in the. A) efflux transporter knockout strains and B) efflux transporter 
overexpressing strains. The data is normalized to the relative fluorescence values of the WT control 
strain (ParaB-venus and pTrc99A in WT). All of the strains were induced with 5 mM arabinose. 
Overexpression of the the efflux transporters was induced with 2 mM IPTG except for the 
overexpression of setC and ydeE where 0.2 mM IPTG was used. 
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Figure 2.10. Efflux promoter transcriptional fusions. Reporters are in WT background and the data is 
normalized to the relative fluorescence values when no arabinose is added. All of the strains were 
induced with 10 mM arabinose. 
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CHAPTER 3: Targeted rational approach to simultaneous sugar co-
utilization in Escherichia coli 
 
3.1 Introduction and background 
The goal of this project is to engineer a strain that is efficient in co-utilizing multiple sugars 
simultaneously. As mentioned previously, the three main sugars of concern are glucose, 
arabinose and xylose. In the case where all three sugars are present in a mixture, E. coli will 
consume glucose first, then arabinose and then finally xylose. During the consumption of each 
individual sugar, a diauxic shift exists and this lag phase results in inefficient consumption of the 
sugar mixture. To find a solution to this problem, it is necessary to study the hierarchy that 
exists between glucose, arabinose, and xylose consumption and research possible ways to 
eliminate this hierarchy. Previous work has been devoted towards investigating the glucose-
arabinose hierarchy as well as the hierarchy that exists between arabinose and xylose [56]. 
Current findings on the glucose-xylose hierarchy, however, have not been thoroughly studied. 
Given the central role of PTS and CRP in glucose-mediated catabolite repression, a significant 
amount of research has been devoted to exploring the use of ptsG (glucose-specific transporter 
of the PTS) knockouts as a strategy for enabling simultaneous sugar utilization [92]. Mutations 
in ptsG have been investigated and successful results have been achieved. It was previously 
shown that in E. coli, deletion of the ptsG gene can remove catabolite repression at the expense 
of a lower glucose uptake rate [45]. The time required to complete fermentation of sugar 
mixtures in rich medium has been greatly decreased [93]. However, similar results have not 
been achieved in mineral salts medium, which is particularly desirable for commercial processes 
[94]. Mutations that activate CRP can also result in higher co-utilization of sugars. However, 
because CRP is a global regulator controlling the expression of approximately 200 promoters 
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[95], its activation leads to a large-scale reprogramming of cellular physiology. The significances 
of these changes are not known and rather than attempting to analyze every change possible, 
other approaches to engineering a strain capable of co-utilizing sugars are more desirable. 
Our goal is to eliminate repression of the metabolic and transport genes of xylose, without 
affecting cAMP or CRP. The operon responsible for the metabolism of xylose in E. coli is 
regulated by other genes such as xylR and araC. We proposed a mechanism by which this 
operon could be controlled by a constitutively “on” promoter, so that it is not affected by 
repression of other genes. This allows expression of the xylose metabolic genes even in 
multiple sugar mixtures where catabolite repression would normally result in repression of the 
xylAB operon and cease xylose metabolism. To do this we first replaced the xylA promoter with 
a tetRA element and selected on tetracycline. We then replaced the tetRA element with a 
constitutively “on” promoter and selected on minimal xylose plates (to ensure functionality of the 
xylA operon). A schematic diagram for the proposed promoter replacement is shown in Figure 
3.1.  
3.2 Materials and methods 
Media and growth conditions. Luria-Bertani liquid and solid medium (10 g/L tryptone, 5 g/L 
yeast extract, 10 g/L NaCl) was used for routine bacterial culture and genetic manipulation. All 
experiments were performed in M9 minimal media (6 g/L Na2 HPO4, 3 g/L KH2 PO4, 0.5 g/L 
NaCl, 1 g/L NH4 Cl, 1 mL of a 1 M solution of MgSO4. 7H2O, 50 µL of 1M solution of CaCl2) at 
37°C. Antibiotics were used at the following concentrations: ampicillin at 100 µg/mL, 
chloramphenicol at 20 µg/mL, and kanamycin at 40 µg/mL unless otherwise noted.  All 
experiments involving the growth of cells carrying the helper plasmid pKD46 were performed at 
30 oC. Loss of pKD46 was achieved by growth at 42 oC under nonselective conditions on LB 
agar. Sugars were added at 20mM concentrations for overnight cultures and experiments 
unless otherwise specified. The sugars and antibiotics were sterile filtered before adding them 
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to the growth flasks. Primers were purchased from IDT, Inc. Enzymes were purchased from 
New England Biolabs and Fermentas. 
Tetracycline counter selection. Chromosomal tetracycline counter-selection was done using 
the method described previously [96]. Briefly, the method consists of two steps. In the first step, 
the region of interest to be mutated was first replaced with a tetRA element from the transposon 
Tn10. This was done using λ-Red recombination using the plasmid pKD46. The resultant strain 
is resistant to tetracycline and was selected for on tetracycline plates. In the second step, the 
tetracycline resistance marker on the plates was replaced by the desired mutation. The strain 
CR1264 was made by first replacing the xylA promoter (region 3727343-3727450) with a tetRA 
element. The tetRA element was then moved into a clean wild-type background by P1vir 
transduction. The tetRA element was then replaced by the PLtetO-1 promoter amplified from the 
pPROTet.E plasmid. The PLtetO-1 promoter was amplified using primers KK148fii (sequence: 5’- 
GAA TTA CCC AGT TTC ATC ATT CCA TTT TAT TTT GCG AGC GCT TAG CTC CTG AAA 
ATC TCG) and KK148r (sequence: 5’- CGA GCT GGT CAA AAT AGG CTT GCA TAT TGA 
ACT CCA TAA TGG TCA GTG CGT CCT GCT GAT), where the underlined sequence is the 
region on the pPROTet.E plasmid. This was done using λ-Red recombination using the plasmid 
pKD46 and the colonies were selected for on minimal (M9) xylose plates. Colonies from these 
plates were then re-streaked on LB plates, first at 42°C and then at 37°C.  
Strain and plasmid construction. Bacterial strains and plasmids used in this study are 
described in Tables 4.1 and 4.2 respectively. All strains are isogenic derivatives of Escherichia 
coli K-12 strain MG1655. All cloning steps were performed in E. coli strain DH5α (phi-80d 
lacΔm15 enda1 recA1 hsdR17 supE44 thh-1 gyrA96 relAΔlacU169). The generalized 
transducing phage P1vir was used in all genetic crosses according to standard methods [19]. 
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The plasmid pAraE (pKK046) was constructed by first amplifying the araE gene (region 
2978766-2980223) using primers KK141f (sequence: 5’- ATC GAA TTC CTC TCT GCT GGC 
AGG AAA AA) and KK141r (sequence: 5’- ATC GGT ACC AGC ACA TCC GGC CCG TGA AA). 
The PCR product was then digested with EcoRI and KpnI (sequences underlined) and cloned 
into pPROTet.E (Clontech) under the control of a strong promoter, PLTetO-1 [97]. The plasmid 
pXylE (pKK047) was constructed by first amplifying the xylE gene (region 4238782-4240296) 
using primers KK140f (sequence: 5’- ATC GAA TTC AGA ATG GTC TAA GGC AGG TC) and 
KK140r (sequence: 5’- ATC GGA TCC GGC GCG GCG TGC TGG ACA GG). The PCR product 
was then digested with EcoRI and BamHI (sequences underlined) and cloned into pPROTet.E. 
The pPDC AdhB was constructed by Kori Dunn (unpublished) in a sequential process. First, the 
pdc gene from Zymomonas mobilis (ZM4) [98] was amplified using the primer sequences: 5’- 
ATG CGA ATT CTA TAT GGA GTA AGC AAT GAG TTA TAC TGT CGG TAC C (forward) and 
5’- ATG CGG ATC CCT AGA GGA GCT TGT TAA CAG GC (reverse). The PCR product was 
then digested with EcoRI and BamHI and cloned into pPROTet.E, resulting in plasmid pPDC. 
The adhB gene was amplified from Zymomonas using primers: 5’- ATG CGG ATC CAG GAG 
TGT TAT AGC TAT GGC TTC TTC AAC TTT TTA TAT TCC (forward; bold letters are the 
added sequence for an optimal ribosome binding site for cloning in E. coli) and 5’- ATG CCT 
GCA GGA AAT TAG AAA GCG CTC AGG (reverse). The PCR product was digested with 
BamHI and PstI and cloned into plasmid pPDC to yield pPDC AdhB.  
CRIM integrations were performed in accordance to the method described by Haldimann and 
Wanner [99].  In order to carry out the araE integration, the region consisiting of the araE gene 
controlled by the PLTetO-1 promoter from the pAraE plasmid was first amplified. The primers used 
for this amplification are KK161f (sequence: 5’- ATC CTG CAG TCG AGT CCC TAT CAG TGA 
TA) and KK141r. For the integration of xylE, the region consisiting of the xylE gene controlled by 
the PLTetO-1 promoter from the pXylE plasmid was amplified. The primers used for this 
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amplification are KK161f and KK140r. The PCR products were then digested with PstI and KpnI 
and cloned into the multiple cloning sites of pAH143K and pAH153C. The pAH143K and 
pAH153C plasmids were constructed by Lon Chubiz (unpublished), in which the gentamicin 
resistant gene in pAH143 and pAH153 CRIM plasmids is replaced by the kanamycin and 
chloramphenicol resistant genes respectively.  The region containing the pdc and adhB genes in 
the pPROTet.E plasmid, controlled by the PLTetO-1 promoter was amplified from the plasmid using 
primers KK161f and KK180r (ATC TCT AGA GAA ATT AGA AAG CGC TCA GG). The PCR 
product was digested with PstI and XbaI and cloned into the multiple cloning sites of pAH143K, 
yielding plasmid pKK052. The CRIM helper plasmids pAH69 (helper plasmid for CRIM plasmid 
pAH143K) and pAH123 (helper plasmid for CRIM plasmid pAH153C) were used to complete the 
integrations in E.coli and the integrated plasmids were moved into different mutant strains by 
P1vir transduction. 
Kinetic growth experiments. Single colonies were picked from freshly streaked plates and 
grown overnight in glass test-tubes containing 3 ml of minimal medium (M9) and 20mM glucose. 
For preliminary kinetic growth measurements, overnight cultures were subcultured to an OD of 
0.05 in fresh medium and 150 µL was transferred to 96-well microtiter plates. Plates were 
sealed with Breath-Easy membranes (Diversified Biotech) to reduce evaporation. The 
temperature was maintained at 37°C and OD600 readings were taken every 20 minutes. 
For shake flasks growth experiments, the overnight cultures were inoculated in pre-sterilized 
250 mL Erlenmeyer shake flasks containing 50 mL of M9 and 20mM total concentration of 
sugars. The initial OD600 after inoculation was set to 0.02. The temperature and agitation rate 
were set at 37°C and 500 rpm respectively. The optical densities of the cultures were measured 
every 30 minutes at a wavelength of 600 nm in 1.5 cm cuvettes using a spectrophotometer. 
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Analytical measurements. Sugar concentrations were measured using high-performance 
liquid chromatography (HPLC). Cells were first grown overnight in test tubes with M9 
supplemented with glucose (20 mM). The cells were then subcultured 1:30 into fresh M9 
supplemented with the appropriate sugars and were grown in test tubes. Periodically, a sample 
was first filtered using a 0.22 µm pore size filter (Millipore) and then run on a Gilson HPLC 
equipped with an autosampler, a cation exchange Aminex HPX-87H column (Bio-Rad), and an 
evaporative light scattering detector (ELSD). The column was operated at a temperature of 
65°C. A 10 mM Formic Acid (HPLC grade) solution was used as the mobile phase and run 
isocratically at a flow rate of 0.6 mL/min. Each sample was run through the column for 15 
minutes (retention times for glucose and xylose are 10.12 and 11.1 minutes respectively). The 
chromatogram peaks were analyzed using the Gilson Safire software. All experiments were 
conducted in triplicates and average values with one standard deviation error bars are reported. 
3.3 Results 
Replacing the xylA promoter with a constitutive promoter improves co-utilization in a 
mixture of sugars, but results in poor xylose utilization. Growth curves of wild-type E. coli 
demonstrate a diauxic shift in a mixture of sugars. As mentioned before, our primary focus is on 
improving xylose metabolism and overcoming the inhibiting effects of catabolite repression in 
the presence of glucose. In order to gain an understanding of how the two sugars are utilized in 
the cell, two main analyses were made. First, we produced growth curves in minimal media to 
observe how the cells grow in 1) individual sugars and 2) mixtures of sugars. Second, we 
analyzed specifically how each of these sugars was utilized by the cell over time.  
The growth curves for wild-type E. coli in individual sugars are shown in Figure 3.2 (glucose) 
and Figure 3.3 (xylose). Figure 3.4 shows the growth of the cells when grown in a mixture of 
glucose and xylose. The diauxic shift is clearly visible between 9 hrs and 12 hrs. There is a 
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distinct lag phase during which one sugar (glucose) is completely consumed and the cells are 
preparing to use the next sugar in line (xylose). Using HPLC analysis, we were also able to 
measure extracellular sugar concentrations over time. This gives a measure of how the cells are 
utilizing each sugar during the course of their growth. Cells were supplemented with 2mM of 
each sugar and allowed to grow for eight hours. Figure 3.5 shows the depletion of the sugars for 
six hours of growth. What is most evident from this analysis is that in a glucose-xylose mixture, 
the cells only start to consume xylose when all the glucose is depleted. This is in agreement 
with the diauxic shift we observe in growth curves. Glucose is consumed to completion within 
four hours whether it is the sole carbon source or not. The cells take longer to consume xylose 
(five hours) when it is the sole carbon source.  
To compare the performance of our engineered strain (CR1264) with the wild-type strain, we did 
similar growth and sugar utilization analyses. A micro-plate reader was used for a quick 
overnight kinetic growth measure. The results for the individual sugars as well as glucose-
xylose mixtures are shown in Figures 3.6, 3.7 and 3.8. The engineered strain grows normally on 
glucose. In a mixture of sugars, however, we can see a distinct difference between the growth 
of the engineered strain and that of wild-type. While the diauxic shift is completely eliminated in 
the engineered strain, we observe that the cells grow much slower than the wild-type cells. We 
can see the reason for this effect more clearly in Figure 3.8. The engineered strain does not 
grow as well in xylose as the wild-type strain. It should be noted, however, that this strain is able 
to use xylose as the sole carbon source and cultures reach normal OD600 levels when left to 
grow overnight. The growth rate in xylose, however, was significantly decreased. These results 
are also confirmed by HPLC analysis (Figure 3.9). We see that there is no xylose depletion 
even after eight hours of growth. 
Adding a transporter to the engineered strain significantly improves co-utilization of 
sugars. We hypothesized that the reason the engineered strain was not able to efficiently utilize 
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xylose was due to transport limitations. Even though our strain now had a constitutive promoter 
that was able to control metabolism of xylose effectively, there were still restrictions on how 
xylose was getting into the cell. To account for this, we constructed plasmids with the arabinose 
low affinity transporter araE and the xylose low affinity transporter xylE. Previous work has 
suggested that these transporters are not sugar specific [100]. Therefore, in the absence of 
arabinose, araE should be able to transport xylose and hence it is worth testing this transporter 
along with the native transporter for xylose.  
The results showed a significant increase in co-utilization of the two sugars (Figure 3.10 shows 
the growth curve for the strain with the araE transporter and Figure 3.11 shows the growth for 
the strain with the xylE transporter). With the addition of a transporter, the diauxic shift was 
completely eliminated and the engineered strain was able to grow faster than the wild-type 
strain. Where the wild-type E. coli strain was lagging during consumption of the individual 
sugars, the engineered strain was growing continuously and faster.  
The analysis of the individual sugars was less straightforward. Growth in glucose was 
comparable to the wild-type cells for both the CR1264::pAraE and CR1264::pXylE strains 
(Figures 3.12 and 3.13). The growth for the strain with the araE transporter was not as fast as 
the wild-type strain, but this was due to the fact that there was a discrepancy in the OD’s of the 
overnight cultures before subculturing; the OD of the wild-type culture was higher than that of 
the engineered strain. Growth in xylose of the engineered strain was definitely improved with the 
addition of the transporters, but not restored to wild-type levels (Figures 3.14 and 3.15). In order 
to makes sure that the lack of the diauxic shift was not just a delayed diauxic shift, OD 
measurements were taken well beyond 24 hours and up to 48 hours to confirm that the 
stationary phase was in fact reached. 
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HPLC analysis confirmed what we observed with the growth curve experiments when the 
strains were grown in a glucose-xylose mixture (Figures 3.16 and 3.17). The sugars are 
simultaneously depleted, which suggests co-utilization of glucose and xylose by these strains. 
The individual sugars are consumed similarly to the wild-type strains, with glucose being 
depleted within four hours and xylose within five hours of growth. The discrepancy between 
these results and the growth curve results suggests that there may be more complicated 
pathways involved in growth of the cells that do not necessarily reflect sugar consumption 
directly.  
The addition of the araE transporter, rather than the xylE transporter, proved to be better 
for growth on xylose. The addition of transporters to the engineered strain significantly 
increased co-utilization of glucose and xylose. The transporters were also individually integrated 
into the chromosome of the engineered strain, CR1264, to produce strains CR1265 (araE 
integrated) and CR1266 (xylE integrated). The transporters in this case were controlled by the 
constitutive PLTetO-1 promoter and hence their expression was not inhibited by catabolite 
repression effects. The growth and sugar utilization in these strains was analyzed once again to 
determine which strain proved to be the most efficient in co-utilization. While both CR1265 and 
CR1266 showed improved co-utilization, the strain with an araE transporter showed better 
growth on xylose. Strains CR1267 and CR1268 were also tested to confirm that the attachment 
sites for integration don’t affect the results that we see. The results for CR1267 are reported. 
Figures 3.18, 3.19 and 3.20 show the growth curves for glucose only, xylose only and glucose-
xylose sugar mixtures respectively. HPLC analysis confirmed improved co-utilization for this 
engineered strain (Figure 3.21). 
Co-utilization was observed even in anaerobic conditions. To confirm that our strain was 
not exhibiting favorable properties only in conditions in which oxygen was available, we 
repeated the experiments in purely anaerobic conditions. Experiments were carried out in 
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sealed Erlenmeyer shake flasks (with a side spout) that were sparged with nitrogen prior to the 
start of the experiment. Time-point OD measurements were taken as described before except 
that the samples were drawn from the side spout using a sterile BD 5mL syringe with a 
disposable needle (Luer-LokTM Tip with BD Precision GlideTM Needle 22G x 1 ½ (0.7mm 
40mm)) so as not to allow oxygen to enter the sealed flask. As expected, in anaerobic 
conditions the growth is affected and hence the OD’s were all lower than before for the same 
time period. However, the strain still displayed improved co-utilization properties in a glucose-
xylose sugar mixture. It can be seen from Figure 3.22 that the diauxic shift is absent in both 
oxygen limiting (or micro-aerobic) and anaerobic conditions. Additionally, we can see from 
Figure 3.23, that the sugar utilization is also similar in anaerobic conditions. Xylose is consumed 
simultaneously with glucose in a glucose-xylose mixture and is consumed in exactly the same 
time period as when the strain is grown in micro-aerobic conditions. This is an important result 
as it verifies that our engineered strain can be grown in an anaerobic environment (which is 
typical of a fermentation reactor) and still utilize sugars simultaneously. 
Adaptation of the engineered strain to xylose did not improve xylose utilization. In an 
effort to improve the growth of the strain CR1267 on xylose, we applied an evolutionary 
approach. Cells were subcultured every day for three weeks in fresh minimal media 
supplemented with 20 mM xylose. The hope was that the cells would eventually adapt in a 
xylose environment and their growth would be improved on xylose as the sole substrate. After 
two weeks of adaptation, it was observed that the cultures started to become dense faster than 
before and that growth on xylose was definitely improved, with final OD’s much higher than the 
strain CR1267.  
The challenge, however, was that the characteristics of this strain were not consistent from one 
day to the next. Growth curve experiments performed on different days resulted in inconsistent 
results. Results also varied between different colonies from the same plate. The second 
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problem was that even when the final OD was higher than the wild-type strain, the kinetic 
growth trend of this strain did not follow the exponential curve. Rather there was a long lag 
phase during which the cells did not grow at all and then suddenly grew rapidly (Figure 3.24). 
HPLC analysis does not explain this lag in growth. According to the sugar utilization analysis, 
the xylose seems to be depleting as fast as in the wild-type strain. The adapted strain would 
have to be sequenced and the mutations analyzed to determine what exactly is causing the 
variation in properties and whether xylose utilization in this strain is in fact improved.  
3.4 Discussion 
We have shown that by replacing the native xylA promoter with a constitutive promoter that is 
not restricted by catabolite repression effects, we can significantly improve co-utilization of 
glucose and xylose in E. coli.  
As previously mentioned in the introductory chapter, there are several factors affecting efficient 
utilization of a mixture of sugars. A combination of factors involving metabolism, transport and 
regulation is the key to achieving efficient co-utilization. Replacement of the xylA promoter with 
a constitutive promoter attacked the problem of negative regulation of this operon in the 
presence of glucose and ensured metabolism of xylose. However, this strain’s efficiency was 
limited by transport of xylose into the cell. This was fixed by introducing transporters such as 
araE and xylE, under the control of a strong promoter, into the cell. While this solution 
significantly improved co-utilization, growth on xylose as the sole carbon source was still not 
restored. This suggests that there are other factors that come into play whenever changes are 
introduced into a metabolic pathway. The exact responses to these changes are unknown but 
the effect is noticed when the strain is grown on xylose as the only substrate. When the strains 
are grown in a mixture of glucose and xylose, however, the properties of the engineered strain 
meet our goals and more efficient utilization of the sugar mixture takes place. We do not know 
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for a fact whether these positive changes are because catabolite repression effects are 
overcome as this has not been directly tested. It is, however, our hypothesis that the 
replacement of the xylA promoter with a constitutively “on” promoter, which is unaffected by 
catabolite repression responses of the cell, helps to express the metabolic genes of xylose even 
in the presence of glucose.  
The addition of the araE transporter helped the engineered strain grow on xylose better than the 
addition of the xylE transporter. However, HPLC analysis of these two strains showed that the 
sugars were consumed in exactly the same way; xylose did not seem to be utilized faster in the 
CR1264::pAraE strain. The reason for this discrepancy is not known.  
Another important question to ask is whether there are detrimental effects to the bacteria with 
the introduction of these metabolic changes. For example, the increase in metabolism of sugars 
leads to a build-up of sugar phosphates and hence a stronger drive towards the methylglyoxal 
pathway. The methylglyoxal pathway diverts carbon from the lower branch of glycolysis to 
produce methylglyoxal. This diversion helps bacterial cells maintain the rate of carbon flux by 
temporarily relieving the stress caused by phosphorylated intermediates (such as sugar 
phosphates) and allows the cells to grow for a limited time until phosphate balance is restored. 
However, in the scenario that the flux balance is continually not maintained by the cell, the 
production of methylglyoxal continues to dangerous levels, causing cell death. If this is the case, 
it is important to investigate whether causing mutations to the cell to improve co-utilization also 
causes toxicity.  
The success of this approach opens doors to more possibilities in engineering a more efficient 
strain for co-utilizing sugars. The methodology can be used to solve the problem of the glucose-
arabinose sequential utilization as well. A similar replacement of the araB promoter with a 
constitutive promoter could lead to better co-utilization of glucose and arabinose and eventually 
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all three sugars prominently present in hemicellulose. Furthermore, this engineering approach 
can also be extended to improve the transport of pentose sugars into the cell. 
The final construction of our engineered strain that showed the most efficiency in co-utilization 
of glucose and xylose is CR1267. To summarize, this strain has the native xylA promoter 
replaced with a constitutive promoter (PLtetO-1 ) and an araE transporter that is controlled by a 
strong promoter PLtetO-1 integrated at the ϕ80 attachment site of the E. coli chromosome.  
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3.5 Figures and tables 
Table 3.1. Bacterial strains used in this work. 
Strain Genotype or relevant characteristics
a Source or 
reference
b,c 
   
MG1655 F
-
 λ
-
 ilvG rph-1 CGSC #7740 
DH5α 
phi-80d lac∆m15 enda1 recA1 hsdR17 supE44 thh-1 gyrA96 
relA∆lacU169 
New England 
Biolabs 
CR1263 ∆PxylA::tetRA  
CR1264 ∆PxylA::PLtetO-1  
CR1265 ∆PxylA::PLtetO-1 attHK022::pKK048  
CR1266 ∆PxylA::PLtetO-1 attHK022::pKK049  
CR1267 ∆PxylA::PLtetO-1 att ϕ80::pKK050  
CR1268 ∆PxylA::PLtetO-1 att ϕ80::pKK051  
CR1269 ∆PxylA::PLtetO-1 att ϕ80::pKK050 attHK022::pKK052  
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Table 3.2. Plasmids used in this work. 
Plasmids Genotype or relevant characteristics
a
 
Source or 
reference
b,c
 
   
pKD46 bla PBAD gam bet exo pSC101 ori(ts)  
pAH143K kan MCS tL3 rgnB attHK022 oriR6K Lon Chubiz 
pAH153C cm MCS tL3 rgnB attϕ80  oriR6K Lon Chubiz 
pAH69 bla IntHK022 oriR6K  
pAH123 bla Int ϕ80 oriR6K  
pPDC AdhB cm PLtetO-1 pdc adhB ori ColE1 Kori Dunn 
pPROTet.E cm  PLtetO-1 ori ColE1 Stratagene 
pKK046 (pAraE) cm PLtetO-1 araE ori ColE1  
pKK047 (pXylE) cm PLtetO-1 xylE ori ColE1  
pKK048 kan PLtetO-1 araE tL3 rgnB attHK022 oriR6K  
pKK049 kan PLtetO-1 xylE  tL3 rgnB attHK022 oriR6K  
pKK050 cm PLtetO-1 araE tL3 rgnB attϕ80  oriR6K  
pKK051 cm PLtetO-1 xylE tL3 rgnB attϕ80  oriR6K  
pKK052 kan PLtetO-1 pdc adhB  tL3 rgnB attHK022 oriR6K  
 
a. All strains are isogenic derivatives of E. coli K-12 strain MG1655. 
b. All strains and plasmids are from this work unless otherwise noted. 
c. E. coli Genetic Stock Center, CGSC, Yale University. 
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Figure 3.1. Approach for the replacement of the xylA promoter with a constitutive promoter. 
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Figure 3.2. Growth curve of wild-type in glucose. Cells were grown in M9 with 20 mM glucose as the 
sole carbon source.  
 
Figure 3.3. Growth curve of wild-type in xylose. Cells were grown in M9 with 20 mM xylose as the sole 
carbon source. 
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Figure 3.4. Growth curve of wild-type in a mixture of glucose and xylose. Cells were grown in M9 
with glucose (10 mM) and xylose (10 mM).  
 
Figure 3.5. Sugar utilization in wild-type (HPLC analysis). Cells were supplemented with 2 mM sugar 
concentrations and allowed to grow for eight hours.  
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Figure 3.6. Growth curve of the engineered strain (CR1264) and wild-type (WT) in glucose. Cells 
were grown in M9 with 20 mM glucose as the sole carbon source.  
 
Figure 3.7. Growth curve of the engineered strain (CR1264) in xylose. Cells were grown in M9 with 
20 mM xylose as the sole carbon source. 
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Figure 3.8. Growth curve of the engineered strain (CR1264) in a mixture of glucose and xylose. 
Cells were grown in M9 with glucose (10 mM) and xylose (10 mM).  
 
Figure 3.9. Sugar utilization in the engineered strain (CR1264). Cells were supplemented with 2 mM 
sugar concentrations and allowed to grow for eight hours. 
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Figure 3.10. Growth curve of the engineered strain with pAraE (glucose + xylose). Cells were grown 
in M9 with 10 mM glucose and 10 mM xylose. 
 
Figure 3.11. Growth curve of the engineered strain with pXylE (glucose + xylose). Cells were grown 
in M9 with 10 mM glucose and 10 mM xylose. 
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Figure 3.12. Growth curve of the engineered strain with pAraE (glucose). Cells were grown in M9 
with 20 mM glucose as the sole carbon source. 
 
Figure 3.13. Growth curve of the engineered strain with pXylE (glucose). Cells were grown in M9 
with 20 mM glucose as the sole carbon source. 
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Figure 3.14. Growth curve of the engineered strain with pAraE (xylose). Cells were grown in M9 with 
20 mM xylose as the sole carbon source. 
 
Figure 3.15. Growth curve of the engineered strain with pXylE (xylose). Cells were grown in M9 with 
20 mM xylose as the sole carbon source. 
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Figure 3.16. Sugar utilization in strain CR1264::pAraE. Cells were supplemented with 2 mM sugar 
concentrations and allowed to grow for eight hours.  
 
Figure 3.17. Sugar utilization in strain CR1264::pXylE. Cells were supplemented with 2 mM sugar 
concentrations and allowed to grow for eight hours.  
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Figure 3.18. Growth curve of the engineered strain with the araE transporter integrated (glucose). 
Cells were grown in M9 with 20 mM glucose as the sole carbon source. 
 
Figure 3.19. Growth curve of the engineered strain with the araE transporter integrated (glucose + 
xylose). Cells were grown in M9 with glucose (10 mM) and xylose (10 mM). 
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Figure 3.20. Growth curve of the engineered strain with the araE transporter integrated (xylose). 
Cells were grown in M9 with 20 mM xylose as the sole carbon source.  
 
Figure 3.21. Sugar utilization in CR1267. Cells were supplemented with 2 mM sugar concentrations 
and allowed to grow for eight hours.  
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Figure 3.22. Growth curve of the CR1267 strain in micro-aerobic and anaerobic conditions. Cells 
were grown in M9 with 10 mM glucose and 10 mM xylose. 
 
Figure 3.23. Sugar utilization in strain CR1267 under micro-aerobic and anaerobic conditions. 
Cells were supplemented with 10 mM glucose and 10mM xylose and allowed to grow until stationary 
phase. 
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Figure 3.24. Growth curve of the adapted CR1267 strain in xylose. Cells were grown in M9 with 20 
mM xylose as the sole carbon source. 
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CHAPTER 4: Further engineering of strain CR1267 for analysis of 
ethanol production under anaerobic conditions 
 
4.1 Introduction  
The description of a strain that is more efficient than wild-type E. coli in co-utilizing glucose and 
xylose simultaneously was given in the previous chapter. It was concluded that strain CR1267 
showed the most co-utilizing efficiency as shown by growth curve experiments and sugar 
utilization (HPLC) analysis. This strain had the native xylA promoter replaced with a constitutive 
promoter and was supplemented with the araE transporter.  
In this chapter, we describe how the strain CR1267 was engineered further to optimize it for 
ethanol production. Two main changes to the engineered strain and the experimental conditions 
were made. First, in order to maximize ethanol production we introduced the genes pdc 
(pyruvate decarboxylase) and adhB (alcohol dehydrogenase II) from Zymomonas mobilis [101, 
102] to divert the production of organic acids to ethanol as the principal fermentation product in 
E. coli [103]. Secondly, all experiments were carried out in a purely anaerobic environment to 
emulate fermentation conditions.  
With the addition of these changes, we repeated the growth experiments to observe anaerobic 
growth. Previously, we had monitored the sugar utilization of our engineered strain for eight 
hours only and started with a sugar concentration of only 2 mM. In these experiments, however, 
we monitored sugar utilization of the strain throughout its growth period in the 20 mM 
concentrated sugar media. We also analyzed the ethanol and acetate concentrations in the 
wild-type cultures during the growth period to quantify ethanol production. This serves as a 
preliminary step to allow for further analysis for our engineered strain in the future. 
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4.2 Materials and methods 
Media and growth conditions as well as strain and plasmid construction is described in the 
previous chapter. The strain and plasmids specifically used in this study are CR1267, CR1269, 
pPDC AdhB, and pKK052 (Tables 3.1 and 3.2). 
Anaerobic growth experiments. Single colonies were picked from freshly streaked plates and 
grown overnight in glass test-tubes containing 3 mL of minimal medium (M9) and 20mM 
glucose. The cultures were then inoculated in pre-sterilized 250 mL Erlenmeyer shake flasks 
(with a side spout) containing 150 mL of M9 and 20mM total concentration of sugars. The initial 
OD600 after inoculation was set to 0.02. To maintain anaerobic growth conditions, nitrogen was 
sparged into the flasks through a 0.22 µm pore size filter for 15 minutes and sealed with a 
rubber stopper at both openings. The temperature and agitation rate were set at 37°C and 500 
rpm respectively. Five milliliters of a culture was withdrawn periodically from the shake flasks’ 
side spouts using a sterile BD 5mL syringe with a disposable needle (Luer-LokTM Tip with BD 
Precision GlideTM Needle 22G x 1 ½ (0.7mm 40mm)). 1mL of the withdrawn culture was 
transferred to a 1.5 cm cuvette and the OD600 was measured using a spectrophotometer. The 
rest of the withdrawn culture was used for ethanol and sugar concentration analysis. All 
experiments were conducted in triplicates and average values with the standard deviations are 
reported. 
Analytical measurements. To measure sugar concentrations, samples were first filtered using 
a 0.22 µm pore size filter (Millipore) and diluted 50% with deionized, autoclaved water before 
running them on the HPLC. The dilution step was necessary because the chromatogram peaks 
reach a maximum at 10mM sugar concentration due to software limitations. Operating 
conditions were the same as described in the previous chapter. The chromatogram peaks were 
analyzed using the Gilson Safire software.  
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Ethanol and acetate concentrations were determined by GC/MS at the metabolomics center of 
the University of Illinois at Urbana-Champaign. The culture samples were first filtered using a 
0.22 µm pore size filter prior to submission to the metabolomics center. The following protocol is 
provided by Alexander Ulanov from the metabolomics center. Samples (1 µL) were injected in 
split mode (5:1) to the GC/MS system consisting of an Agilent 7890 gas chromatograph, an 
Agilent 5975 mass selective detector and HP 7683B (Agilent Inc, Palo Alto, CA, USA) 
autosampler. Analysis was done on a 30 m ZB-WAXplus column with 0.32 mm I.D. and 0.25 m 
film thickness (Phenomenex, Torrance, CA, USA) with an injection port temperature of 2000C. 
The interface was set to 2000C, and the ion source adjusted to 2300C. The helium carrier gas 
was set at a constant flow rate of 3 mL/min. The temperature program was as follows: 6 minutes 
isothermal heating at 550C, followed by an oven temperature increase of 200C/min to 1700C for 
0 minutes and then 100C/min to 2200C for 2 minutes. The mass spectrometer was operated in 
positive electron impact mode (EI) at 69.9 eV ionization energy in m/z 25-300 scan range.  
The spectra of all chromatogram peaks were evaluated using the HP Chemstation (Agilent, Palo 
Alto, CA, USA) program. Identification and quantification of samples was performed using the 
mass spectra obtained from the authentic standards and additionally confirmed with NIST08 
and W8N08 libraries (John Wiley & Sons, Inc., USA). 
4.3 Results 
Confirming simultaneous co-utilization of the engineered strain in anaerobic conditions. 
Before the pdc and adhB genes were introduced in our engineered strain, we wanted to verify 
that the simultaneous co-utilization of glucose and xylose is still observed for the specific 
experimental conditions described above. The engineered strain, therefore, was grown under 
anaerobic conditions and the extracellular sugar concentrations were measured over the course 
of growth and compared to wild-type strains grown under the same conditions. Figure 4.1 shows 
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that the engineered strain still consumes the two sugars simultaneously. This is a vast 
improvement to the wild-type strain, where the depletion of xylose remains stationary until all the 
glucose in the culture has been utilized. This result confirms that our strain still retains its 
desired properties under the conditions that will be required to test for ethanol yields. 
Ethanol production in wild-type E. coli. In order to have a model to compare our results with, 
we first carried out measurements for the wild-type E. coli strain without any mutations or 
plasmids in anaerobic conditions. The OD growth curves and sugar utilization results are similar 
to that obtained under aerobic or oxygen limiting conditions as described in Chapter 3 and are 
therefore not shown here. The end-point ethanol and acetate production for different sugar 
mixtures are reported in Table 4.1. Ethanol production values cannot be compared with 
previous studies in the literature because of variations in experimental conditions and 
fermentation reactor volumes. Hence, it is important to have this reference standard in our 
study. Figure 4.2 shows how the ethanol production varies over time when the cells are grown 
in a glucose-xylose mixture. It can be seen from this graph that between 9.5 hrs and 11 hrs, the 
ethanol concentration is constant, hence indicating that the ethanol production is stagnant. This 
is in agreement with the diauxic shift observed between 9 hrs and 11 hrs in the growth curve 
when cells are grown in a glucose-xylose mixture (Figure 3.4).  
Ethanol production in wild-type E. coli containing the plasmid pPDC AdhB. Following the 
experiments carried out with wild-type E. coli, we proceeded to repeat the experiments with the 
strain WT::pPDC AdhB (wild-type strain containing the pProtet.E plasmid with the pdc and adhB 
genes cloned). With the introduction of the pdc and adhB genes, the ethanol concentrations 
would be expected to increase and the acetate production would be decreased. The final optical 
densities of the cells and sugar utilization, however, would be expected to stay approximately 
the same. We confirmed that the growth is unaffected when the pdc and adhB genes are 
introduced in the wild-type strain and grown on glucose (Figure 4.3). Figures 4.4 and 4.5 
93 
 
illustrate the growth on xylose and a glucose-xylose mixture respectively. The growth on xylose 
is affected slightly and the cells reach lower optical densities than wild-type cells grown without 
the pdc and adhB genes. This result is evident in both figures 4.4 and 4.5. In a glucose-xylose 
mixture, the cells grow much more slowly after all the glucose has been consumed. The slow 
xylose consumption rate after the glucose is consumed is probably due to a combination of 
cellular inhibitory effects resulting from the formation of by-products such as succinic acid, lactic 
acid, acetic acid, ethanol, and formic acid. Additionally, when cells are grown in xylose as the 
sole carbon source, the final optical density reached is about 0.2 lower. HPLC analysis of this 
strain confirms that the strain utilizes glucose and xylose in a sequential manner (Figure 4.6). 
Note that only when all the glucose has been consumed, does the organism begin to utilize 
xylose. The beginning of xylose consumption occurs at about 11 hours of growth. This is in 
strong agreement with the growth curve data, where we see that at the 11th hour, the cells begin 
to grow exponentially after a lag period of two hours (between 9-11 hrs of growth). Finally, 
analysis of the ethanol and acetate concentrations in the extracellular environment confirm that 
the addition of the pdc and adhB genes into the wild-type strain does in fact drive the production 
of ethanol as the principal fermentation product in E. coli (Table 4.2). The ethanol 
concentrations are higher than in the wild-type strain (an increase from 0.4 g/L to 2.1 g/L when 
grown in glucose) and the acetate production is reduced (from 30.9 mM to 13.2 mM when 
grown in glucose).  
Ethanol production in wild-type E. coli with the pdc and adhB genes integrated. To avoid 
the addition of antibiotics to the fermentation process, we integrated the pdc and adhB genes 
into the chromosome under the control of the PLTetO-1 promoter. The growth experiment, HPLC 
analysis and ethanol analysis were repeated with this strain to check for consistency. Figures 
4.7, 4.8, and 4.9 illustrate the growth of this strain on glucose, glucose-xylose mixture, and 
xylose respectively. The growth is exactly the same as the strain WT::pPDC AdhB. The HPLC 
94 
 
results show that the sugar utilization of this strain is also consistent (Figure 4.10). Glucose was 
consumed within 16 hours of growth and xylose was consumed within 17 hours. In a mixture of 
glucose and xylose all the glucose was consumed within 10 hours of growth. During the time 
between 9 hrs and 11 hrs the xylose concentration was constant as no xylose is utilized by the 
cells. At about the 11th hour of growth, xylose utilization was initiated and xylose was completely 
consumed after approximately 25 hours. Ethanol analysis showed that the ethanol and acetate 
production is similar to the strain WT::pPDC AdhB. These results verified that the integration of 
the ethanol producing genes, pdc and adhB did not affect the characteristics of the wild-type 
strain except for improving ethanol production.  
Ethanol production in the engineered strain CR1269. Verification of the successful 
integration of the pdc and adhB genes into the wild-type strain shows that integration of these 
genes does not change the characteristics of the strain. This is important so that we can 
successfully incorporate these ethanol producing genes into our engineered strain without 
compromising its favorable characteristics. The final step, therefore, was to integrate the pdc 
and adhB genes into our engineered strain, CR1267, to produce the final strain CR1269. To test 
the performance of this strain, it is necessary to simulate fermentation conditions more 
accurately where anaerobic conditions, temperature, pH, and pressure are more tightly 
regulated.  
4.4 Discussion 
The design of the final engineered strain CR1269 is described pictorially in Figure 4.11. To 
summarize, this strain has the native xylA promoter replaced with a constitutive promoter  
(PLtetO-1 ), an araE transporter that is controlled by a strong promoter PLtetO-1 integrated at the ϕ80 
attachment site and the pdc and adhB genes integrated at the HK022 site of the E. coli 
chromosome also controlled by the PLtetO-1 promoter. 
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The addition of the pdc and adhB genes into our strains verified that the ethanol production can 
be increased in strains of E. coli and other mixed fermentation products (such as acetate) can 
be reduced. Furthermore, we proved that the engineered strain shows co-utilization of sugars 
even when grown in anaerobic conditions. This is important because it confirms that 
fermentation conditions do not affect the characteristics of our engineered strain. The results 
shown in this chapter help to verify that our engineered strain would be able to co-utilize sugars 
just as well in anaerobic conditions as in micro-aerobic conditions and with the aid of the ethanol 
producing genes pdc and adhB further increase in ethanol yields can be achieved.  
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4.5 Figures and tables 
Table 4.1. End-point ethanol and acetate concentrations for wild-type E. coli. 
Glucose Glucose-Xylose mixture Xylose 
Ethanol (g/L) Acetate (mM) Ethanol (g/L) Acetate (mM) Ethanol (g/L) Acetate (mM) 
0.4 30.9 0.3 22.9 0.3 24.2 
 
Table 4.2. End-point ethanol and acetate concentrations for the strain WT::pPDC AdhB. 
Glucose Xylose 
Ethanol (g/L) Acetate (mM) Ethanol (g/L) Acetate (mM) 
2.1 ± 0.2 13.2 ± 2.1 1.9 ± 0.2 13.1 ± 1.9 
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Figure 4.1. Sugar utilization of the engineered strain CR1267 versus the wild-type strain under 
anaerobic conditions. Cells were supplemented with 10 mM glucose and 10 mM xylose and allowed to 
grow until stationary phase was reached. 
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Figure 4.2. Production of ethanol over time in the wild-type strain. Cells were grown in M9 with 
glucose (10 mM) and xylose (10 mM). Samples were filter sterilized before ethanol was analyzed. 
 
Figure 4.3. Growth curve of WT::pPDC AdhB in glucose. Cells were grown in M9 with 20 mM glucose 
as the sole carbon source.  
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Figure 4.4. Growth curve of strain WT::pPDC AdhB in a mixture of glucose and xylose. Cells were 
grown in M9 with glucose (10 mM) and xylose (10 mM).  
 
Figure 4.5. Growth curve of strain WT::pPDC AdhB in xylose. Cells were grown in M9 with 20 mM 
xylose as the sole carbon source. 
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Figure 4.6. Sugar utilization in strain WT::pPDC AdhB. Cells were supplemented with 20 mM sugar 
concentrations (total) and allowed to grow until stationary phase was reached. 
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Figure 4.7. Growth curve of strain WT::pKK052 in glucose. Cells were grown in M9 with 20 mM 
glucose as the sole carbon source.  
 
Figure 4.8. Growth curve of strain WT::pKK052 in a mixture of glucose and xylose. Cells were 
grown in M9 with glucose (10 mM) and xylose (10 mM).  
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Figure 4.9. Growth curve of strain WT::pKK052 in xylose. Cells were grown in M9 with 20 mM xylose 
as the sole carbon source. 
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Figure 4.10. Sugar utilization in strain WT::pKK052. Cells were supplemented with 20 mM sugar 
concentrations (total) and allowed to grow until stationary phase was reached. 
 
 
 
Figure 4.11. Design of the final engineered strain CR1269. 
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CHAPTER 5: Conclusions and recommendations 
 
5.1 Analysis of efflux transporters: conclusions 
We identified thirteen arabinose efflux transporters. Eight of these transporters showed an 
increase in intracellular arabinose concentrations when deleted. Six of these transporters 
showed a decrease in intracellular arabinose concentration when over expressed, and 
overexpression of twelve of these transporters proved to be toxic to the cell. None of these 
transporters had an effect on xylose metabolism. 
We also investigated the possible substrates for the identified efflux transporters. Our results 
suggest that arabinose is a substrate for most of these transporters and ribulose may be a 
substrate for KgtP. We also studied the effects of these transporters on tolC mutants and found 
that most of these transporters are tolC dependent. Our final transcriptional reporter results also 
showed that the promoters of these transporters are arabinose inducible. 
To summarize, we have identified sugar export as one of the key mechanisms of sugar 
transport for the cell. We have studied candidate efflux transporters for arabinose and showed 
that deletion of these transporters may lead to higher metabolism of arabinose in E. coli. This 
study allows us to develop a novel method to regulate the expression of genes involved in the 
sugar metabolic pathways within the cell.  
5.2 Analysis of efflux transporters: recommendations for future work 
Our experimental analysis gives an indirect measure of sugar metabolism in the cell. We did not 
directly measure the intracellular concentration of arabinose. Rather, we only have data to prove 
that the promoter activity of the gene that is responsible for arabinose breakdown (araB) is 
affected with the presence of these transporters in the cell. Further investigation would be 
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required to confirm whether intracellular arabinose concentration is affected. Our results 
suggest that arabinose accumulation is inhibited by the presence of these transporters. 
However, we have not confirmed that efflux is the only mechanism by which this occurs. Other 
possible mechanisms may exist, which need to be further investigated and/or ruled out.  
It is also important to analyze why the cell would have a mechanism in which sugars are 
effluxed from the cell. Our hypothesis is that these systems exist to expel harmful sugar 
analogues (such as ribulose-5-phosphate and methylglyoxal). However, we have not confirmed 
this with experimental data, or identified the substrates for these efflux transporters.  
A step further would be to identify and analyze efflux transporters for xylose. We studied 31 
transporters and none of these showed any effect on intracellular xylose concentration. 
However, the candidate genes that we chose to study were picked based on homology to ydeA, 
which is known to efflux arabinose. These transporters could be substrate specific and hence 
we do not observe any effects with xylose. For future work, it is more advantageous to study 
ways in which we can improve xylose metabolism in the cell because xylose is most abundant 
in hemicellulose and yet least utilized during fermentation. Identifying a possible way to increase 
intracellular xylose concentrations in the cell and overcoming transport limitations would prove 
to be favorable for making the biofuel production process more efficient.  
5.3 Strain engineering design: conclusions 
Through rational strain engineering, we successfully built an E. coli strain capable of 
simultaneously co-utilizing sugars in a mixture of glucose and xylose. This strain was able to 
grow in a mixture of glucose and xylose without a diauxic shift or lag in growth due to sequential 
sugar utilization. HPLC results also confirmed that both sugars are utilized at the same time 
during the growth period of the cell. Our engineered strain retained these favorable 
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characteristics in aerobic as well as anaerobic conditions and can therefore be used in the 
industry for large-scale biofuels production. 
5.4 Strain engineering design: recommendations for future work 
The natural next step would be to test the engineered strain in a fermenter and measure ethanol 
yields to quantitatively measure its performance. Ethanol yields of 0.49 have previously been 
achieved, which is very close to the theoretical value of 0.51. In order to compare the 
performance of our engineered strain to that of others’, it would be necessary to test the growth 
and ethanol production of these strains in similar fermentation conditions.  
Another aspect that is not fully understood in our experiments is the changes in kinetic growth of 
the cells. One of the effects we observed with growth curves of our engineered strain is that the 
strains grow very poorly on xylose as the sole carbon source. The reason for this is not known. 
One possible explanation is that the cell is inhibited by mixed acid fermentation products and 
that the mutations introduced to improve co-utilization may make the cell more susceptible to 
these inhibitory affects. However, this has not been tested and the metabolic pathways have not 
been fully analyzed to determine whether the mutations are causing these changes in growth.  
In addition, it is also recommended that different constitutive promoters be tested. Varying the 
strength of the promoter that is controlling the expression of the xylose metabolic genes may 
have differing effects on how the strain grows on xylose as the sole carbon source. Ribosomal 
promoters (PrecA) are possible options. Other promoters include synthetic promoters, which are 
also good alternatives as the strength of the promoter can be varied [104]. 
Finally, this approach of strain design can be applied to other metabolic genes in the xylose 
pathway and extrapolated to include the arabinose pathway as well. This would serve to 
overcome catabolite repression effects in the presence of glucose. Since CRP is not affected 
with this approach of strain engineering, we don’t need to compensate for unwanted changes in 
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cell physiology that may develop with changes that are caused to the CRP regulatory system. 
This provides us with a novel approach towards strain design and helps to engineer a strain that 
is capable of metabolizing all the sugars in biomass most efficiently for maximum biofuel yields. 
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